PRODUCT LIST
Active Pharma Ingredients
API Acid Reflux Disorders
Product Pharmacopoeia CAS No. Technical Document
A Acotiamide Hydrochloride - 773092-05-0 -
Almagate EP 66827-12-1 -
Aluminum Hydroxide BP, USP 21645-51-2 -
C Cimetidine - 51481-61-9 -
D Dexlansoprazole - 138530-94-6 - Dexlansoprazole - 313640-86-7 DMF Sesquihydrate Dexrabeprazole Sodium - 171440-18-9 ODMF, Tech Pack
E Ecabet Sodium - 86408-72-2 DMF
Esomeprazole - 119141-88-7 - Esomeprazole Magneisum - 217087-10-0 - Dihydrate Esomeprazole Magnesium - 161973-10-0 - Esomeprazole Magnesium USP 217087-09-7 CEP, DMF Trihydrate Esomeprazole Potassium IHS 161796-84-5 DMF
Esomeprazole Sodium - 161796-78-7 - Esomeprazole Zinc/ 793668-08-3, - - Base/Strontium 119141-88-7 F Famotidine - 76824-35-6 -
E Glycopyrrolate - 596-51-0 -
H Hydrotelcite BP 12304-65-3 -
I Ilaprazole IHS, IP 172152-36-2 DMF
Ilaprazole Sodium - 172152-50-0 ODMF, Tech Pack
Itopride - 122898-67-3 -
Itopride Hydrochloride IHS 122892-31-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 1 API Acid Reflux Disorders
Product Pharmacopoeia CAS No. Technical Document
L Lafutidine - 118288-08-7 -
Lansoprazole - 103577-45-3 -
Lansoprazole Sodium - 226904-00-3 -
M Magaldrate USP 74978-16-8 - Misoprostol 1% dispersion - 51922-46-2 - in HPMC 1H NMR, CoA, HPLC, Nizatidine - 76963-41-2 N Mass, IR O Omeprazole - 73590-58-6 -
Omeprazole Magnesium - 95382-33-5 -
Omeprazole Sodium - 95510-70-6 -
Oxethazaine - 126-27-2 -
Oxyphenonium Bromide - 50-10-2 -
P Pantoprazole EP, USP 102625-70-7 -
Pantoprazole Magnesium - 471293-63-7 -
Pantoprazole Sodium - 138786-67-1 ODMF, Tech Pack Pantoprazole Sodium 164579-32-2, - - Sesquihydrate 154644-14-1 Pirenzepine Dihydrochloride EP 29868-97-1 USFDA Monohydrate Propantheline Bromide - 50-34-0 -
R Rabeprazole - 117976-89-3 -
Rabeprazole Sodium - 117976-90-6 -
Ranitidine - 66357-35-5 -
Ranitidine Hydrochloride - 66357-59-3 - 90098-04-7, Rebamipide - - 111911-87-6
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 2 API Acid Reflux Disorders
Product Pharmacopoeia CAS No. Technical Document
Roxatidine Acetate - 93793-83-0 - Hydrochloride S Siltenzepine - 98374-54-0 -
Sucralfate BP, EP, JP, USP 54182-58-0 -
T Tenatoprazole Sodium - 335299-59-7 ODMF, Tech Pack
Troxipide - 30751-05-4 -
V Vonoprazan Base - 881681-00-1 -
Vonoprazan Fumarate - 881681-01-2 -
Z Zinc L-Carnosine - 132613-07-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 3 API Allergy Management
Product Pharmacopoeia CAS No. Technical Document
A Acrivastine IHS 87848-99-5 ISO
Adrenaline Acid Tartrate USP 51-42-3 -
Alimemazine BP, EP 84-96-8 -
Alinastine - 154541-72-7 -
Asapiprant - 932372-01-5 -
B Bamifylline Hydrochloride - 20684-06-4 -
Bamirastine - 215529-47-8 -
Bepotastine Besylate - 190786-44-8 -
Bilastine - 202189-78-4 -
Bilastine N-Oxide - 2069238-47-5 - Bromophenaromine BP, EP, USP 980-71-2 - Maleate C Carbinoxamine Maleate - 3505-38-2 USDMF
Cetirizine Dihydrochloride BP, USP 83881-52-1 WC
Chlorpheniramine Maleate BP, USP 113-92-8 EDMF, USDMF
D Desloratadine - 100643-71-8 USMDF
Dimetindene Maleate - 3614-69-5 CEP
Diphenhydramine - 58-73-1 -
Diphenhydramine Citrate USP 88637-37-0 - Diphenhydramine BP, IP, USP 147-24-0 - Hydrochloride Doxylamine Succinate EP, USP 562-10-7 WC
E Ebastine BP, EP, USP 90729-43-4 WC
Ebastine Fumarate - 97928-20-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 4 API Allergy Management
Product Pharmacopoeia CAS No. Technical Document
Embramine - 3565-72-8 -
Embramine Hydrochloride - 13977-28-1 -
Episnastine Hydrochloride - 108929-04-0 -
F Fexofenadine Base - 83799-24-0 -
Fexofenadine Hydrochloride - 153439-40-8 - 1244-76-4, Hydroxyzine Hydrochloride - - H 2192-20-3 K Ketotifen Fumarate - 34580-14-8 -
L Levocetirizine - 130018-77-8 USDMF Levocetirizine - 130018-87-0 - Dihydrochloride Levocetirizine BP, EP, IP, JP, USP 823178-28-5 - Hydrochloride Loratadine - 79794-75-5 -
M Mepyramine Maleate BP, EP 59-33-6 -
Mequitazine BP, EP, USP 29216-28-2 GMP
Methdilazine Hydrochloride - 1229-35-2 ISO9001
Mizolastine - 108612-45-9 - Oxomemazine - 4784-40-1 - O Hydrochloride P Pheniramine Maleate BP, EP, USP 132-20-7 -
Phenylephrine BP, IP, USP 59-42-7 -
Phenylephrine Bitartarate BP, USP 14787-58-7 - Phenylephrine - 61-76-7 - Hydrochloride S Suplatast Tosilate - 94055-76-2 -
T Thozylamine - 91-85-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 5 API Allergy Management
Product Pharmacopoeia CAS No. Technical Document
Triprolidine Hydrochloride BP, EP, USP 6138-79-0 WC
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 6 API Anaemia Management
Product Pharmacopoeia CAS No. Technical Document
A Argatroban USP 141396-28-3 -
C Calcium Folinate USP 1492-18-8 GMP, WHO-GMP
Calcium Levofolinate - 80433-71-2 cGMP
D Daprodustat - 960539-70-2 -
Deferasirox - 201530-41-8 -
F Ferric Carboxy Maltose - 9007-72-1 -
Ferric Citrate - 3522-50-7 -
Ferric Maltol - 33725-54-1 -
Ferrocenecarboxaldehyde - 12093-10-6 cGMP, ISO
Ferrous Ascorbate - 24808-52-4 -
Ferrous Fumarate BP, IP, USP 141-01-5 -
Ferrous Sodium Citrate - 144314-88-5 -
Ferrous Succinate - 10030-90-7 -
Ferrous Sulphate - 7720-78-7 DC-Grade
Ferrous Sulphate Dried - 13463-43-9 -
Ferumoxytol - 722492-56-0 -
Folic Acid EP, BP, USP 59-30-3 DMF, CEP Iron III Hydroxide Poly - 1310-14-1 - I Maltose Complex Iron Isomaltoside - 1370654-58-2 -
Iron Polymaltose Complex - 53858-86-9 -
Iron Sorbitol IHS 1338-16-5 -
Iron Sucrose - 8047-67-4 DMF, WC
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 7 API Anaemia Management
Product Pharmacopoeia CAS No. Technical Document
Iron(III) Hydroxide - 20344-49-4 -
Iron(III) Hydroxypolymaltose IHS 79173-09-4 -
Iron-Dextran - 9004-66-4 -
M Methylcobalamin Hydrate - 288315-09-3 -
Methylene Blue - 7220-79-3 -
Methylthioninium Chloride BP, EP 122965-43-9 - DMF, ISO14001:2004, N Nandrolone Decanoate - 360-70-3 ISO9001:2008, Tech Pack, USFDA DMF, ISO14001:2004, Nandrolone Laurate BP, EP, IP, USP 26490-31-3 ISO9001:2008, Tech Pack, USFDA P Phytonadione (Vitamin K1) - 84-80-0 -
R Rivipansel Sodium - 1189037-60-2 ISO
Roxadustat - 808118-40-3 -
S Sevelamer Carbonate - 845273-93-0 DMF
Sevelamer Hydrochloride - 152751-57-0 DMF Sodium Ferric Gluconate - 34089-81-1 - Complex Sucroferric Oxyhydroxide - 12134-57-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 8 API Anthelmintics
Product Pharmacopoeia CAS No. Technical Document
A Alibendol - 26750-81-2 -
Avermectin (Abamectin) - 73989-17-0 -
B Benznidazole - 22994-85-0 -
Buparvaquone - 88426-33-9 -
C Clorsulon - 60200-06-8 -
Cymiazole - 61676-87-7 -
D Diethyl Carbamazine Citrate BP, IP, USP 1642-54-2 -
Diloxanide Furoate BP 3736-81-0 -
F Febantel BP, EP, IP 58306-30-2 -
Fenbendazole BP 43210-67-9 -
Fexinidazole 59729-37-2 -
I Ivermectin EP 7.0 70161-11-4 -
L Levamisole 14769-73-4 -
Levamisole Hydrochloride EP 16595-80-5 -
Levamisole Phosphate 32093-35-9 -
M Mebendazole BP, EP, USP 31431-39-7 -
Mepacrine Hydrochloride - 6151-30-0 -
Miltefosine - 58066-85-6 -
Morantel Tartrate BP, EP, USP 26155-31-7 -
Moxidectin - 113507-06-5 -
N Niclosamide - 50-65-7 -
Nifursemizone - 5579-89-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 9 API Anthelmintics
Product Pharmacopoeia CAS No. Technical Document
Nitazoxanide - 55981-09-4 -
O Oxfendazole - 53716-50-0 -
Oxyclozanide BP 2277-92-1 -
P Piperazine Adipate - 142-88-1 -
Piperazine Citrate - 144-29-6 -
Praziquantel - 55268-74-1 -
Pyrantel Pamoate/Embonate EP, IP, JP, USP 22204-24-6 -
Pyrvinium - 7187-62-4 -
R Rafoxanide BP 37052-78-9 -
Rafoxanide Suspension - 22662-39-1 -
Ricobendazole - 54029-12-8 -
S Symetine - 15599-45-8 -
T Triclabendazole - 68786-66-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 10 API Antiemetics
Product Pharmacopoeia CAS No. Technical Document
A Alizapride - 59338-93-1 ODMF, Tech Pack
Aprepitant - 170729-80-3 Tech Pack
Azasetron Hydrochloride - 141922-90-9 -
B Buclizine Hydrochloride - 129-74-8 - DMF, GMP, ISO, WHO Clebopride Maleante - 57645-91-7 C GMP D Difenidol Hydrochloride - 3254-89-5 -
Dimenhydrinate BP, EP, USP 523-87-5 -
Dolasetron - 115956-12-2 GMP, WHO GMP
Dolasetron Mesylate USP 115956-13-3 DMF
Domperidone - 57808-66-9 -
Domperidone Maleate BP, EP, IP 99497-03-7 -
F Fosaprepitant - 172673-20-0 -
Fosaprepitant Dimeglumine - 265121-04-8 -
Fosnetupitant - 1703748-89-3 -
G Granisetron EP, USP 109889-09-0 WC
Granisetron Hydrochloride - 107007-99-8 -
H Hyoscine Hydrobromide - 138-12-5 GLP, GMP, ISO
M Maropitant - 147116-67-4 - Meclizine Dihydrochloride - 31884-77-2 - Monohydrate Meclizine Hydrochloride - 1104-22-9 -
Metopimazine - 14008-44-7 WC
N Nabilone - 51022-71-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 14 API Antiemetics
Product Pharmacopoeia CAS No. Technical Document
Netupitant - 290297-26-6 -
O Ondansetron Base USP 116002-70-1 -
Ondansetron Hydrochloride IHS, IP, EP, USP 99614-01-04 - Ondansetron Hydrochloride - 103639-04-9 - Dihydrate Ondonsetron IP, USP 99614-02-5 WC
P Palonosetron Hydrochloride - 135729-62-3 -
Prochloroperazine Mesylate BP, EP, IP, JP, USP 84-02-6 -
Prochlorperazine Maleate - 58-38-8 -
Prochlorperazine Mesylate BP, EP, IP, USP 5132-55-8 - Promethazine - 58-33-3 - Hydrochloride Promethazine Theoclate BP, EP, IP, USP 17693-51-5 -
R Ramosetron Hydrochloride - 132907-72-3 -
Ricasetron - 117086-68-7 -
Rolapitant - 552292-08-7 - Trimethobenzamide - 554-92-7 - T Hydrochloride Tropisetron - 89565-68-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 15 API Antifungals
Product Pharmacopoeia CAS No. Technical Document
A Abafungin - 129639-79-8 -
Albaconazole - 187949-02-6 -
Amorolfine Hydrochloride - 78613-38-4 -
Anidulafungin - 166663-25-8 - EDQM, USFDA, Bifonazole - 60628-96-8 B WHO Geneva Butenafine - 101828-21-1 -
Butenafine Hydrochloride - 101827-46-7 -
Butoconazole Nitrate - 64872-77-1 GMP
C Caspofungin Diacetate - 179463-17-3 -
Chlorphenesin BP, IP 104-29-0 -
Chlorphenesin Carbamate JP 886-74-8 USDMF, WHO GMP
Clotrimazole - 23593-75-1 ISO, SMS, USAC
D Dapaconazole - 1269726-67-1 ISO
E Eberconazole - 128326-82-9 -
Eberconazole Nitrate - 130104-32-4 -
Echinocandin B - 54651-05-7 -
Econazole - 27220-47-9 - 68797-31-9, Econazole Nitrate - GMP 24169-02-6 Efinaconazole - 164650-44-6 Tech Pack
Embeconazole - 329744-44-7 -
Enilconazole - 73790-28-0 -
F Fenticonazole IHS 72479-26-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 16 API Antifungals
Product Pharmacopoeia CAS No. Technical Document
Fenticonazole Nitrate - 73151-29-8 -
Fluconazole - 86386-73-4 -
G Genaconazole - 120924-80-3 -
Griseofulvin BP, EP 126-07-8 GMP
I Ichthammol USP 8029-68-3 -
Iodiconazole - 887138-63-8 -
Isavuconazole - 241479-67-4 -
Isavuconazonium Sulfate - 946075-13-4 -
Isoconazole Nitrate BP, EP 24168-96-5 -
Itraconazole - 84625-61-6 -
K Ketoconazole - 65277-42-1 -
Lanoconazole - 101530-10-3 -
L Lipopeptide - 171263-26-6 -
Liranaftate - 88678-31-3 -
Luliconazole - 187164-19-8 -
M Micafungin - 235114-32-6 -
Micafungin Sodium - 208538-73-2 -
Miconazole - 22916-47-8 -
Miconazole Nitrate - 22832-87-7 -
N Naftifine Hydrochloride - 65473-14-5 -
O Oxiconazole Nitrate - 64211-46-7 - Piroctone Olamine + FDA, GMP, ISO, - 84775-94-0 P Phenoxyethanol ISO14001, REACH
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 17 API Antifungals
Product Pharmacopoeia CAS No. Technical Document
1H NMR, CoA, HPLC, Posaconazole - 171228-49-2 Mass, IR R Ravuconazole - 182760-06-1
S Sertaconazole - 99592-32-2 -
Sertaconazole Nitrate EP 99592-39-9
Sulconazole - 61318-90-9 -
Sulconazole Nitrate USP 82382-23-8 -
T Tavaborole - 174671-46-6 USDMF
Terbinafine - 291161-71-6 -
Terbinafine Hydrochloride BP, EP, JP, USP 78628-80-5 Tech Pack , DMF
Terconazole BP, EP, USP 67915-31-5 DMF
Tioconazole BP, EP, IHS, USP 65899-73-2 DMF
Tolnaftate - 2398-96-1 -
Trilostane - 13647-35-3 -
V Voriconazole - 137234-62-9 -
Z Zinc Undecenoate - 557-08-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 18 API Anti Gout
Product Pharmacopoeia CAS No. Technical Document
A Allopurinol - 315-30-0 -
B Benzbromarone - 3562-84-3 -
C Colchicine (Form-A) - 64-86-8 -
44060-53-7, Febuxostat - - F 144060-53-7
L Lesinurad (RDEA594) - 878672-00-5 -
P Probenecid - 57-66-9 -
S Sodium Citrate - 68-04-02 -
T Topiroxostat - 577778-58-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 19 API Antimalarials
Product Pharmacopoeia CAS No. Technical Document
A Amodiaquine Base - 86-40-2 EDQM, USFDA, WHO Geneva
Arteether - 75887-54-6 -
α, β- Arteether - 123492-25-1 GLP, GMP, ISO
Artemether - 71963-77-4 -
Artesunate - 88495-63-0 Tech Pack
C Chloroquine Diphosphate BP, EP, USP 50-63-5 GMP, WHO GMP
Cinchonidine - 485-71-2 EU-GMP, WHO GMP
Cinchonine - 118-10-5 EU-GMP, WHO GMP
D Dihydro Artemisinin - 71939-50-9 EDQM, USFDA, WHO Geneva 81496-81-3, Dihydroartemisinin - - 71939-50-9 H Hydroxychloroquine - 118-42-3 -
Hydroxychloroquine Sulfate - 747-36-4 -
L Lumefantrine USP 82186-77-4 -
M Mefloquine - 53230-10-7 -
N Naphthoquine Phosphate - 173531-58-3 -
P Piperaquine Phosphate - 4085-31-8 -
Primaquine Diphosphate - 63-45-6 GMP
Proguanil Hydrochloride BP, EP, USP 637-32-1 Tech Pack, WC
Q Quinine - 130-95-0 EDQM, USFDA, WHO Geneva EDQM, USFDA, Quinine Bisulphate - 549-56-4 WHO Geneva Quinine Dihydrochloride - 60-93-5 EDQM, USFDA, WHO Geneva 6119-47-7, EU-GMP, WHO GMP, Quinine Hydrochloride BP 130-89-2 Tech Pack
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 20 API Antimalarials
Product Pharmacopoeia CAS No. Technical Document
Quinine Sulphate BP, USP 6119-70-9 WC
Quinidine Base - 56-54-2 GLP, GMP, ISO
Quinidine Sulphate - 6591-63-5 GLP, GMP, ISO
S Sulphadoxine BP, EP, USP 2447-57-6 -
T Tefenoquine - 106635-80-7 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 21 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
A Acedia Sulphone - 80-03-5 -
Acetyl Kitasamycin - 178234-32-7 ISO
Acetylspiramycin BP 24916-51-6 CP2000
Acriflavinium Chloride - 8048-52-0 -
Amikacin - 253-538-5 -
Amikacin Sulfate - 39831-55-5 GMP
Amoxicillin BP, EP, USP 26787-78-0 -
Amoxicillin Sodium - 34642-77-8 GMP
Amoxicillin Trihydrate - 61336-70-7 -
Amphotericin-B - 1397-89-3 -
Ampicillin - 69-53-4 -
Ampicillin Sodium - 69-52-3 WHO GMP
Ampicillin Trihydrate - 7177-48-2 -
Aspoxicillin - 63358-49-6 -
Atovaquone - 95233-18-4 DMF
Atracurium Besylate - 64228-81-5 -
Avibactam Sodium USP 1192491-61-4 -
Azithromycin BP, EP, IP, USP 83905-01-5 -
Azithromycin Dihydrate BP, EP, IP, USP 117772-70-0 -
Azithromycin Monohydrate - 121470-24-4 - Azithromycin Taste Masking CP 11772-70-0 - Granules 7.5% Azlocillin Sodium - 37091-65-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 22 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Aztreonam - 78110-38-0 GMP
B Bacitracin BP, IP, USP 1405-87-4 -
Bacitracin Zinc - 1405-89-6 -
Balofloxacin - 127294-70-6 Tech Pack
Benzathine Benzylpenicillin - 1538-09-6 GMP
Benzathine Penicillin G USP 41372-02-5 GMP
Benzethonium Chloride - 121-54-0 WC
Benzoic Acid BP, EP, USP 65-85-0 - Benzyl Penicillin Sodium - 69-57-8 GMP (Sterile) Biapenem - 120410-24-4 - Bronopol BP 52-51-7 Tech Pack
C Cadazolid - 1025097-10-2 -
Caderofloxacin Lactate - 1001397-13-2 -
Capreomycin Sulfate - 1405-37-4 -
Caspofungin USP 162808-62-0 -
Cefaclor BP, USP 53994-73-3 GMP, WHO GMP
Cefadroxil - 66592-87-8 GMP
Cefalotin - 153-61-7 GMP
Cefalotin Sodium - 58-71-9 -
Cefamandole Nafate - 42540-40-9 -
Cefapirine Sodium CP 24356-60-3 -
Cefathiamidine - 33075-00-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 23 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Cefazolin Sodium USP 27164-46-1 -
Cefdinir - 91832-40-5 USDMF EU-GMP, ISO, Cefepime - 88040-23-7 WHO GMP ANVISA, DMF, EDQM, Cefepime Hydrochloride - 123171-59-5 MFDS, PMDA, SFDA, TPD, USFDA Cefetamet Pivoxil - 111696-23-2 Hydrochloride Cefiderocol - 1225208-94-5 -
Cefilavancin Trihydrochloride - 1628178-53-9 -
Cefiminox Sodium IHS, USP 75498-96-3 -
Cefixime - 79350-37-1 -
Cefixime Trihydrate - 125110-14-7 -
Cefmenoxime Hydrochloride USP 75738-58-8 -
Cefmetazole Sodium - 56796-39-5 GMP
Cefminox Sodium - 92636-39-0 JDMF
Cefodizime Acid - 69739-16-8 -
Cefodizime Sodium - 86329-79-5 -
Cefodroxil - 50370-12-2 -
Cefonicid Sodium BP, EP, USP 61270-78-8 GMP
Cefoperazone Sodium - 62893-20-3 GMP 64485-93-4, Cefotaxime Sodium - - 478250-23-6 Cefotiam JP 61622-34-2 -
Cefotiam Hexetil - 95761-91-4 EDMF, USDMF Cefotiam Hexetil 95789-30-3, - - Hydrochloride 95761-91-4
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 24 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Cefotiam Hydrochloride - 66309-69-1 -
Cefovecin - 234096-34-5 -
Cefoxitin JP 35607-66-0 GMP
Cefozopran Hydrochloride 113981-44-5 EDMF, USDMF
Cefpirome Sulfate EP 98753-19-6 GMP, WHO GMP
Cefpodoxime Proxetil USP 87239-81-4 EDMF SAMPLE, Tech Pack, Cefprozil 92665-29-7 USDMF, WC 118443-89-3, Cefquinome Sulfate BP, EP, USP - 123766-80-3 Cefradine USP 38821-53-3 COS, EDMF
Ceftazidime - 78439-06-2 GMP, WHO GMP
Ceftazidime Dihydrochloride - 73547-70-3 -
Ceftazidime Sterile - 72558-82-8 -
Ceftezole Sodium - 41136-22-5 -
Ceftibuten - 97519-39-6 -
Ceftibuten Dihyadrate - 118081-34-8 -
Ceftiofur Sodium - 104010-37-9 - 68401-810, EU-GMP, ISO, Ceftizoxime - 68401-82-1 WHO GMP Ceftizoxime Acid Crude USP 68401-81-0 -
Ceftizoxime Sodium (Sterile) - 68401-82-1 - SAMPLE, Tech Pack, Ceftriaxone Sodium - 74578-69-1 USDMF Ceftriaxoxine Sodium Sterile USP 104376-79-6 -
Cefuroxime Axetil - 64544-07-6 EDMF, USDMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 25 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Cefuroxime Sodium USP 56238-63-2 WHO GMP SAMPLE, Tech Pack, Cephalexin BP, USP 15686-71-2 USDMF Cephalexin Monohydrate - 23325-78-2 -
Cephapirin Benzathine BP, EP, IP, USP 97468-37-6 -
Chloramphenicol - 56-75-7 -
Chloramphenicol Base BP, EP, IP, JP, USP 716-61-0 -
Chloramphenicol Palmitate - 530-43-8 - Chloramphenicol Sodium - 982-57-0 - Succinate Sterile Ciclopirox EP, USP 29342-05-0 -
Ciclopirox Olamine - 41621-49-2 -
Cilastatin USP 82009-34-5 -
Cilastatin Sodium - 81129-83-1 -
Ciprofloxacin Base BP, EP, USP 85721-33-1 Tech Pack, WC
Ciprofloxacin Dihydrochloride BP, EP, USP 86483-48-9 WC
Ciprofloxacin Lactate - 97867-33-9 GMP Ciprofloxacin - 93107-08-5 - Monohydrochloride Clarithromycin - 81103-11-9 -
Clarithromycin Citrate - 848130-51-8 WC
Clarithromycine EP 81103-11-9] -
Clavulanate Potassium USP 61177-45-5 - 21462-39-5, Clindamycin Hydrochloride USP - 58207-19-5 Clindamycin Phosphate - 24729-96-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 26 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Clindamycinpalmitate - 25507-04-4 - Hydrochloride Closthioamide - 1227367-59-0 -
Clotiazepam - 33671-46-4 EDMF
Cloxacilin Benzathine BP, EP, IP, JP, USP 23736-58-5 DMF
Cloxacillin BP, IP, USP 61-72-3 -
Cloxacillin Sodium - 7081-44-9 -
Colistimethate Sodium - 8068-37-9 -
D Dalbavacin - 171500-79-1 -
Dapsone BP, EP 80-08-0 WC
Daptomycin - 103060-53-3 -
Delafloxacin - 352458-37-8 - Demeclocycline - 64-73-3 - Hydrochloride Dicloxacillin Sodium - 13412-64-1 -
Difloxacin Base - 98106-17-3 -
Difloxacin Hydrochloride - 91296-86-5 - Dihydrostreptomycin EP 5490-27-7 ISO Sulphate Dirithromycin - 62013-04-1 -
Doripenem - 148016-81-3 -
Doripenem Hydrate BP 364622-82-2 GMP
Doxycycline - 564-25-0 - cGMP, EU-GMP, Doxycycline Hyclate - 24390-14-5 WHO GMP E Enarmycin - 12772-37-1 ISO
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 27 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Enoxacin - 74011-58-8 -
Enramycin - 11115-82-5 -
Enrofloxacin - 93106-60-6 DMF
Enrofloxacin Hydrochloride - 112732-17-9 DMF
Eravacycline - 1207283-85-9 -
Ertapenem - 153832-46-3 GMP
Ertapenem Sodium BP, EP, IP, USP 153773-82-1 -
Erythromycin BP, EP, IP, JP, USP 114-07-8 -
Erythromycin Estolate BP, EP, IP, USP 3521-62-8 -
Erythromycin Ethyl Succinate BP 1264-62-6 -
Erythromycin Lactobionate - 3847-29-8 -
Erythromycin Phosphate BP, EP, IP, JP, USP 4501-00-2 -
Erythromycin Propionate BP, EP, IP, USP 134-36-1 -
Erythromycin Stearate - 643-22-1 -
Erythromycin Thiocyanate - 7704-67-8 -
F Faropenem - 106560-14-9 -
Faropenem Sodium - 122547-49-3 -
Fibracillin - 51154-48-4 -
Finafloxacin - 209342-40-5 -
Flavomycin - 11015-37-5 -
Fleroxacin - 79660-72-3 Chinese SFDA Standard
Flomoxef Sodium - 92823-03-5 GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 28 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Flucloxacillin - 5250-39-5 -
Flucloxacillin Sodium EP 1847-24-1 -
Fosfomycin Calcium EP 26016-98-8 -
Fosfomycin Sodium EP, USP 26016-99-9 -
Fosfomycin Trometamol EP 78964-85-9 DMF
Framycetin Sulfate - 4146-30-9 -
Furacilin - 59-87-0 -
Furaltadone - 139-91-3 ISO
Furaltadone Hydrochloride - 3759-92-0 -
Furazolidone CP 67-45-8 GMP
Furbenicillin Sodium - 54661-82-4 -
Fusidic Acid - 6990-06-3 -
G Garenoxacin - 194804-75-6 -
Garenoxacin Mesylate - 223652-82-2 ODMF, Tech Pack
Gatifloxacin - 112811-59-3 WC
Gatifloxacin Sesquihydrate - 180200-66-2 -
Gemifloxacin Mesylate - 214346-13-1 -
Gentamicin Sulphate - 1405-41-0 -
H Hygromycin B - 31282-04-9 -
I Iclaprim - 192314-93-5 -
Imipenem Crude - 74431-23-5 -
Imipenem - 64221-86-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 29 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Isepamicin Sulfate - 67814-76-0 -
J Josamycin - 16846-24-5 -
K Kanamycin Acid Sulfate - 64013-70-3 -
Kanamycin B - 4696-76-8 -
Kanamycin Mono Sulfate - 25389-94-0 GMP
Kanamycin Sulfate - 70560-51-9 -
Kitasamycin Base IP, USP 1392-21-8 ISO
L Levofloxacin - 100986-85-4 -
Levofloxacin Acid Ester - 106939-34-8 -
Levofloxacin Hemihydrate - 138199-71-0 EDMF, USDMF
Levofloxacin Hydrochloride CP 177325-13-2 -
Levofloxacin Lactate - 294662-18-3 -
Lincomycin Hydrochloride BP, EP, IP, USP 859-18-7 WHO GMP
Linezolid - 165800-03-3 -
Lomefloxacin JP 98079-51-7 -
Lomefloxacin Hydrochloride - 98079-52-8 WC
Lymecycline - 992-21-2 -
M Mafenide - 7761-27-5 -
Marbofloxacin - 115550-35-1 DMF
Meropenem - 119478-56-7 -
Meropenem Trihydrate - 96036-03-2 -
Metronidazole BP, CEP, EP, USP 443-48-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 30 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Metronidazole Benzoate BP, EP, USP 13182-89-3 WC
Mezlocillin Sodium - 59798-30-0 GMP
Minocycline Hydrochloride - 13614-98-7 GMP, WHO GMP EU-GMP, ISO, Mitomycin - 50-07-7 WHO GMP Monensin - 17090-79-8 ISO
Moxifloxacin EP 151096-09-2 - Moxifloxacin Hydrochloride - 186286-86-8 DMF Monohydrate Moxifloxacin Hydrochloride - 186826-86-8 -
Mupirocin - 12650-69-0 -
Mupirocin Calcium - 115074-43-6 -
N Nadifloxacin USP 124858-35-1 -
Neomycin Sulfate - 1405-10-3 -
Nifuratel - 4936-47-4 -
Nitrofurantoin - 67-20-9 CEP, EDMF
Nitrofurantoin Monohydrate - 17140-81-7 -
Norfloxacin Base - 70458-96-7 -
O Octenidine - 71251-02-0 -
Octenidine Hydrochloride - 70775-75-6 WC 82419-36-1, Ofloxacin - ISO 100986-85-4 Olaquindox - 23696-28-8 -
Orbifloxacin - 113617-63-3 -
Ornidazole - 16773-42-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 31 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Oxacillin Sodium - 1173-88-2 -
Oxolinic Acid - 14998-29-4 -
Oxytetracycline BP 79-57-2 GMP Oxytetracycline Dihydrate - 6153-64-6 - (Suitable for INJ Preparation) Oxytetracycline - 2058-46-0 - Hydrochloride Ozenoxacin - 245765-41-7 -
P Panipenem - 87726-17-8 -
p-Anisic Acid USP 100-09-4 -
Paromomycin Sulfate - 1263-89-4 GMP
Pazufloxacin Mesilate BP, EP 163680-77-1 -
Pefloxacin Mesylate - 70458-95-6 WC Pefloxacin Mesylate - 149676-40-4 DMF Dihydrate Pen G Potassium - 113-98-4 IQNET, ISO
Penicillin G Procaine(Sterile) - 6130-64-9 ISO
Pentamidine IP, EP, USP-NF 100-33-4 -
Phenylmercuric Nitrate EP, USP 8003-05-2 -
Piperacillin Sodium - 59703-84-3 CEP, EDMF, USDMF
Piperacillin / Tazobactam - 123683-33-0 DMF
Plazomicin - 1154757-24-0 -
Policresulen - 101418-00-2 GMP, WHO GMP
Polymyxin B Sulfate - 1405-20-5 - 590-00-1, Potassium Sorbate - - 24634-61-5
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 32 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Povidone Iodine - 25655-41-8 -
Pretomanid ,98%NLT - 187235-37-6 -
Procaine Benzylpenicillin BP, IP 54-35-3 -
Proflavine Hemisulphate - 1811-28-5 -
Propyl Paraben - 94-13-3 -
Propyl Paraben Sodium Salt - 35285-69-9 -
R Ramoplanin USP 34 76168-82-6 -
Rifabutin - 72559-06-9 -
Rifalazil BP 2013, USP 35 129791-92-0 -
Rifampicin EP 7.1 13292-46-1 DMF, GMP
Rifaximin EP 80621-81-4 GMP
Roxithromycin - 80214-83-1 -
S Sancycline - 808-26-4 -
Saponins - 8047-15-2 GMP, WHO GMP
Sarafloxacin - 98105-99-8 -
Sarafloxacin Hydrochloride - 91296-87-6 DMF
Secnidazole - 3366-95-8 -
Selenium Sulfide - 7488-56-4 -
Sevoflurane - 28523-86-6 -
Silver Chloride - 7783-90-6 -
Silver Fluoride - 7775-41-9 -
Silver Iodate - 7783-97-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 33 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Silver Iodide - 7783-96-2 -
Silver Nitrate - 7761-88-8 -
Silver Oxide USP 20667-12-3 -
Silver Sulfadiazine - 22199-08-2 -
Silver Sulphate BP, EP, USP 10294-26-5 -
Simeprevir - 923604-59-5 GMP
Sitafloxacin - 127254-12-0 -
S-Methoprene - 65733-16-6 DMF
Sodium Borodeuteride - 15681-89-7 -
Sodium Diacetate - 126-96-5 -
Sodium Ethyl Paraben - 35285-68-8 -
Sodium Sulfadiazine - 547-32-0 -
Sofosbuvir - 1190307-88-0 -
Sparfloxacin - 110871-86-8 DMF 22189-32-8, Spectinomycin Hydrochloride - - 22193-75-5 Spectinomycin Sulfate EP 64058-48-6 ISO
Spiramycin - 8025-81-8 CEP
Spiramycin Adipate - 68880-55-7 -
Spiramycin Embonate - 67724-08-7 -
Streptomycin Hydrochloride BP, EP, USP 6160-32-3 -
Streptomycin Sulfate - 3810-74-0 GMP
Sulbactame - 69388-84-7 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 34 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Sulbenicillin Sodium - 28002-18-8 GMP, WHO GMP
Sulfachlorpyridazine Sodium - 23282-55-5 ISO
Sulfaclozine EP 102-65-8 -
Sulfadiazine BP, EP, USP 68-35-9 GMP
Sulfadimethoxine - 122-11-2 GMP Sulfadimethoxine Sodium - 1037-50-9 GMP, WHO GMP Salt Sulfadimidine - 57-68-1 -
Sulfaguanidine BP, EP, IP 57-67-0 -
Sulfamethizole - 144-82-1 WC
Sulfamethoxazole BP, EP, USP 723-46-6 GMP
Sulfamethoxypyridazine - 80-35-3 GMP
Sulfamonomethoxine - 1220-83-3 - Sulfamonomethoxine BP, EP, USP 38006-08-5 GMP, WHO GMP Sodium Sulfapiridazin Sodium - 2577-32-4 GMP
Sulfapyridine - 144-83-2 -
Sulfaquinoxaline Sodium - 967-80-6 GMP
Sulfasalazine - 599-79-1 -
Sulfisoxazole - 127-69-5 -
Sulphadimidine Sodium BP, USP 1981-58-4 -
Sulphathiazole - 72-14-0 -
Sultamicillin Tosylate - 83105-70-8
Synthetic Camphor - 21368-68-3 GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 35 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
T Taurolidine - 19388-87-5 -
Tazobactam Acid - 89786-04-9 -
Tebipenem Pivoxil - 161715-24-8 GMP
Tedizolid - 856866-72-3 -
Tedizolid Phosphate - 856867-55-5 ODMF, Tech Pack
Teicoplanin Sterile - 61036-62-2 -
Tetracycline EP, USP 60-54-8 GMP
Tetracycline Hydrochloride USP 64-75-5 WC
Tigecycline - 220620-09-7 DMF
Tilmicosin USP 108050-54-0 -
Tilmicosin Phosphate - 137330-13-3 -
Tobramycin - 32986-56-4 -
Tobramycin Sulfate - 49842-07-1 -
Tosufloxacin USP 100490-36-6 -
Triclosan BP, EP, USP 3380-34-5 -
Trimethoprim - 738-70-5 -
Tulathromycin - 280755-12-6 -
Tulathromycin A BP 217500-96-4 GMP, WHO GMP
Tylosin Tartrate - 74610-55-2 -
Tylvalosin Tartrate - 63428-13-7 ISO EU-GMP, ISO, Vancomycin - 1404-90-6 V WHO GMP Vancomycin Hydrochloride - 1404-93-9 GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 36 API Antimicrobials
Product Pharmacopoeia CAS No. Technical Document
Z Zabofloxacin USP 219680-11-2 -
Zinc Bacitracin - 1405-89-6 -
Zinc Carbonate BP, FCC, IP, NF, USP 3486-35-9 - cGMP, FSSC, Zinc Citrate Dihydrate - 5990-32-9 FSSC22000, Halal, Kosher Zinc Citrate Trihydrate - 16039-53-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 37 API Antioxidants
Product Pharmacopoeia CAS No. Technical Document
E Etofylline Clofibrate - 54504-70-0 -
H Hexaethylene Glycol - 2615-15-8 -
Honokiol - 35354-74-6 -
L Lactobionic Acid - 96-82-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 38 API Antiseptics
Product Pharmacopoeia CAS No. Technical Document
B Benzalkonium Chloride BP, EP, JP, USP 8001-54-5 WC
Biclotymol - 15686-33-6 -
C Chlorhexidine Acetate - 56-95-1 -
Chlorhexidine Base BP, EP, IP, JP, USP 55-56-1 -
Chlorhexidine Digluconate - 18472-51-0 GMP, WHO GMP Chlorhexidine BP 3697-42-5 WC Hydrochloride Chlorocresol - 59-50-7 GMP
D Dapivirine - 244767-67-7 -
H Hexamidine Diisethionate - 659-40-5 -
T Thimerosal BP, EP, USP 54-64-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 39 API Antivirals
Product Pharmacopoeia CAS No. Technical Document
A Acycloguanosine/Acyclovir - 59277-89-3 -
Acyclovir Sodium - 69657-51-8 -
Acyclovir EP, USP 59877-89-3 WC
Acyclovir-D4 - 1185179-33-2 -
Adefovir Dipivoxil - 142340-99-6 -
Amenamevir - 841301-32-4 -
Arbidol Hydrochloride - 131707-23-8 -
Asunaprevir BP, EP, USP 630420-16-5 GMP
Atazanavir - 198904-31-3 -
Atazanavir Sulfate - 229975-97-7 -
B Baloxavir Marboxil - 1985606-14-1 -
Boceprevir - 394730-60-0 -
Brivudine - 69304-47-8 -
C Cabotegravir - 1051375-10-0 -
D Daclatasvir Dihydrochloride - 1009119-65-6 -
Daclatavir - 1009119-65-5 -
Danoprevir - 850876-88-9 -
Darunavir Ethanolate - 635728-49-3 -
Dasabuvir - 1132935-63-7 -
Docosanol - 30303-65-2 -
Docosanol (behenyl alcohol) - 661-19-8 -
Doravirine (MK1439) - 1338225-97-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 40 API Antivirals
Product Pharmacopoeia CAS No. Technical Document
E Elbasvir BP, EP, USP 1370468-36-2 GMP
Entecavir - 142217-69-4 -
F Famciclovir - 104227-87-4 -
Foscarnet Sodium - 63585-09-1 -
G Ganciclovir - 82410-32-0 -
I Inosine - 58-63-9 -
L Letermovir - 917389-32-3 -
Lumicitabine - 1445385-02-3 -
M Maraviroc - 376348-65-1 -
Maribavir - 176161-24-3 -
Mericitabine - 940908-79-2 -
N Nelfinavir Mesylate - 159989-65-8 -
Nevirapine - 129618-40-2 -
O Oleuropein - 32619-42-4 -
Ombitasvir - 1258226-87-7 -
Oseltamivir - 196618-13-0 -
Oseltamivir Phosphate - 204255-11-8 -
P Paritaprevir - 1216941-48-8 -
Penciclovir - 39809-25-1 DMF
Peramivir Hydrate - 1041434-82-5 -
Pimodivir - 1629869-44-8 -
Podophyllum Resin - 9005-55-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 41 API Antivirals
Product Pharmacopoeia CAS No. Technical Document
R Ravidasvir Hydrochloride IHS 1303533-81-4 -
Ribavirin - 36791-04-5 -
Ritonavir - 155213-67-5 -
Ruzasvir - 1613081-64-3 -
S Shikimic Acid - 138-59-0 - Sofosbuvir - 1190307-88-0 Tech Pack
Stavudine - 3056-17-5 cGMP
T Telaprevir - 402957-28-2 GMP
Telbivudine - 3424-98-4 -
Tilorone Dihydrochloride - 27591-69-1 -
U Umifenovir - 131707-25-0 -
V Valaciclovir - 124832-26-4 - Valacyclovir Hydrochloride - 124832-27-5 - hydrate Valganciclovir - 175865-60-8 GMP, WHO-GMP 1H NMR, CoA, HPLC, Valganciclovir Hydrochloride - 175865-59-5 Mass, IR Vaniprevir - 923590-37-8 -
Velpatasvir - 1377049-84-7 -
Voxilaprevir - 1535212-07-7 - CEP, EDMF, USDMF, Zidovudine EP 30516-87-1 Z WC
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 42 API Asthma
Product Pharmacopoeia CAS No. Technical Document
A Arformoterol Tartrate - 200815-49-2 -
B Bamaquimast - 135779-82-7 -
Bambuterol Hydrochloride - 81732-46-9 - Chloropyramine - 6170-42-9 WC C Hydrochloride Ciclesonide BP, EP, IP 126544-47-6 USFDA Dextromethorphan BP, EP, USP 6700-34-1 EDMF, WC D Hydrobromide E Ephedrine - 299-42-3 Tech Pack
Ephedrine Hydrochloride - 50-98-6 DMF, USDMF
Ephedrine Sulfate - 134-72-5 Tech Pack
Etamiphylline - 314-35-2 WC
Etamiphylline Camsylate - 19326-29-5 -
Etofylline - 519-37-9 -
F Fevipiprant - 872365-14-5 -
Formoterol Fumarate - 43229-80-7 - Formoterol Fumarate BP, EP, IP, USP 183814-30-4 - Dihydrate I Ibudilast - 50847-11-5 -
L Levalbuterol Sulfate - 148563-16-0 -
Levalbuterol Tartrate - 661464-94-4 -
M Montelucast - 142522-29-8 -
Montelukast - 158966-92-8 -
Montelukast Sodium - 151767-02-1 - AHF-Halal, CNAS(ISO17025), NSF- Osthole - 484-12-8 O cGMP, OU-Kosher, QC, SFDA-GMP, USFDA
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 40 API Asthma
Product Pharmacopoeia CAS No. Technical Document
P Pirfenidone - 53179-13-8 Tech Pack
Potassium Nitrite - 7758-09-0 -
Pranlukast - 103177-37-3 -
Pranlukast Hydrate JP 150821-03-7 JDMF
S Salbutamol IP, USP 18559-94-9 WC
Salbutamol Sulphate BP, EP 51022-70-9 CEP, EDMF, WC
Salmeterol - 89365-50-4 -
Salmeterol Xinafoate EP, USP 94749-08-3 CEP, EDMF, USDMF
Seratrodast - 112665-43-7 -
Setipiprant - 866460-33-5 - Sodium Cromoglicate / - 16110-51-3 - Cromolyn Sodium Sodium Cromoglycate BP, EP, IP, USP 15826-37-6 -
T Terbutaline Sulfate - 23031-32-5 GMP
Tibenelast Sodium - 105102-18-9 -
Tolubuterol Hydrochloride IHS 56776-01-3 EDMF, USFDA
X Xanthine - 69-89-9 -
Z Zafirlukast - 107753-78-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 41 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
A Abemaciclib - 1231929-97-7 -
Abemaciclib Mesylate - 1231930-82-7 -
Abiraterone - 154229-19-3 -
Abiraterone Acetate - 154229-18-2 -
Acalabrutinib - 1420477-60-6 -
Acelarin - 840506-29-8 -
Acolbifene USP 182167-02-8 USDMF, WC 439081-18-2, Afatinib - - 850140-72-6 Afatinib - D6 - 1313874-96-2 -
Afatinib (BIBW 2992) - 439081-18-2 -
Afatinib Dimaleate - 850140-73-7 -
Aldoxorubicin Hydrochloride - 480998-12-7 -
Alectinib - 1256580-46-7 -
Alectinib Hydrochloride - 1256589-74-8 -
Alisertib - 1028486-01-2 -
Alvespimycin - 467214-20-6 -
Amsacrine - 51264-14-3 -
Anagrelide USP 68475-42-3 -
Anastrozole - 120511-73-1 -
Apalutamide (ARN-509) - 956104-40-8 -
Aptinib - 811803-05-1 -
Arsenic Trioxide - 1327-53-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 42 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Atrimustine - 75219-46-4 -
Avapritinib - 1703793-34-3 -
Axitinib - 319460-85-0 -
Azacitidine - 320-67-2 -
B Baccatin-III - 27548-93-2 -
Belinostat - 414864-00-9 -
Bendamustine Hydrochloride - 3543-75-7 - Bendamustine Hydrochloride - 1374784-02-7 DMF 27272 Monohydrate Bentamapimod - 848344-36-5 -
Bexarotene - 153559-49-0 -
Bicalutamide EP 90357-06-5 CEP, COS, DMF
Binimetinib - 606143-89-9 -
Bleomycin EP 11056-06-7 EU-GMP, ISO, WHO GMP
Bleomycin Sulfate - 9041-93-4 GMP, WHO GMP
Bortezomib - 179324-69-7 -
Bosutinib - 380843-75-4 -
Bosutinib Monohydrate - 918639-08-4 -
Brigatinib - 1197953-54-0 -
Brucine Hydrochloride - 5786-96-9 -
Brucine Sulphate - 4845-99-2 -
Buparlisib - 944396-07-0 -
Busereline - 57982-77-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 43 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Busulfan - 55-98-1 -
C Cabazitaxel - 183133-96-2 EDMF, USDMF
Cabozantinib - 849217-68-1
Cabozantinib S-Malate - 1140909-48-3 CGMP, ISO
Camptothecine - 7689-03-4
Canertinib - 267243-28-7 - 154361-50-9, Capacitabine - - 158798-73-3 Capecitabine - 154361-50-9 -
Carboplatin - 41575-94-4 -
Carfilzomib - 868540-17-4 -
Cephalomannine - 71610-00-9 -
Ceritinib - 1032900-25-6 -
Ceritinib Dihydrochloride - 1380575-43-8 -
Cetuximab IHS 205923-56-4 -
Chlorambucil - 305-03-3 - Sample, Tech Pack, Cinacalcet USP 226256-56-0 USDMF Cisplatin - 15663-27-1 EU-GMP, ISO, WHO GMP
Cladribine - 4291-63-8 -
Clodronate Disodium Salt - 22560-50-5 -
Clofarabine - 123318-82-1 USDMF
Copanlisib Hydrochloride - 1402152-13-9 -
Crenolanib Besylate - 670220-93-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 44 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Crizotinib - 877399-52-5 -
Cyclocytidine Hydrochloride - 10212-25-6 GMP, WHO GMP
Cyclophosphamide - 50-18-0 - Cyclophosphamide - 6055-19-2 - Monohydrate Cytarabine - 183133-96-2 -
Cytarabine Hydrochloride - 849217-68-1 GMP, WHO GMP
D Dabrafenib - 1195765-45-7 -
Dacarbazine BP, USP 4342-03-4 -
Dasatinib - 302962-49-8 -
Dasatinib Monohydrate - 863127-77-9 -
Daunorubicin Hydrochloride EP 23541-50-6 CEP, COS, DMF - Decitabine 2353-33-5 -
Decitabine Monohydrate USP 135567-49-6 USDMF
Degarelix Acetate - 214766-78-6 -
Docetaxel - 114977-28-5 -
Docetaxel Trihydrate - 148408-66-6 -
Doxorubicin Hydrochloride EP 25316-40-9 CEP, COS, DMF
Duvelisib - 1201438-56-3 ISO
E Ellipravin - 103461-20-7 -
Enasidenib Mesylate - 1446502-11-9 -
Enzalutamide - 915087-33-1 -
Epirubicin - 56420-45-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 45 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Epirubicin Hydrochloride EP 56390-09-1 CEP, COS, DMF - Erdafitinib 1346242-81-6 - - Eribulin 253128-41-5 - - Eribulin Mesylate 441045-17-6 -
Erlotinib (Form A & B) EP 183321-74-6 DMF
Erlotinib Hydrochloride - 183319-69-9 -
Etanercept IHS 185243-69-0 -
Etoposide - 33419-42-0 -
Evofosfamide - 918633-87-1 -
Exemestane - 107868-30-4
F Famitinib Malate - 1256377-67-9 ISO
Fludarabine - 21679-14-1 -
Fludarabine Phosphate USP 75607-67-9 -
Flutamide - 13311-84-7 -
Fruquintinib - 1194506-26-7 -
Fulvestrant - 129453-61-8 -
G Galunisertib - 700874-72-2 ISO
Gedatolisib - 1197160-78-3 ISO
Gefitinib - 184475-35-2 -
Gemcitabine Base - 95058-81-4 - GMP, WHO-GMP, DMF, Gemcitabine Hydrochloride EP, USP 122111-03-9 JDMF, KDMF, Tech Pack, USDMF, WC Gilteritinib - 1254053-43-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 46 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Glufosfamide - 132682-98-5 -
H Homoharringtonine - 26833-87-4 -
I Ibrutinib - 936563-96-1 -
Idarubicin - 58957-92-9 -
Idarubicin Hydrochloride - 57852-57-0 -
Idelalisib (CAL101) - 870281-82-6 -
Imatinib - 152459-95-5 -
Imatinib Methanesulfonate - 220127-57-1 -
Intoplicine - 125974-72-3 -
Irinotecan Hydrochloride - 100286-90-6 - Irinotecan Hydrochloride - 136572-09-3 - Trihydrate Ixabepilone - 219989-84-1 -
Ixazomib Citrate - 1239908-20-3 -
Ibrutinib - 936563-96-1 -
Idarubicin - 58957-92-9 -
Idarubicin Hydrochloride - 57852-57-0 -
Idelalisib (CAL101) - 870281-82-6 -
Imatinib - 152459-95-5 -
Imatinib Methanesulfonate - 220127-57-1 -
Intoplicine - 125974-72-3 -
Irinotecan Hydrochloride - 100286-90-6 - Irinotecan Hydrochloride USP 136572-09-3 - Trihydrate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 47 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Ixabepilone - 219989-84-1 -
Ixazomib Citrate - 1239908-20-3 - 231277-92-2, Lapatinib - GMP L 231278-20-9 Lapatinib Ditosylate EP,USP 388082-78-8 EDMF, USDMF
Lenalidomide - 191732-72-6 ODMF
Lenalidomide Hydrochloride - 1243329-97-6 -
Lenvatinib - 417716-92-8 -
Lenvatinib Mesylate - 857890-39-2 -
Letrozole - 112809-51-5 -
Leuprorelin - 53714-56-0 -
Leuprorelin Acetate - 74381-53-6 -
Linrodostat - 1923833-60-6 -
Lomustine BP, EP 13010-47-4 -
Lurbinectedin 497871-47-3 - Machlorethamine - 55-86-7 - M Hydrochloride
Masitinib - 790299-79-5 -
Melphalan - 148-82-3 -
Melphalan Hydrochloride - 3223-07-2 USDMF
- Mesna - 19767-45-4
- Methotrexate USP 59-05-2
Methotrexate Disodium Salt - 7413-34-5 GMP
Midostaurin - 120685-11-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 48 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Mitoxantrone Hydrochloride - 70476-82-3 -
Momelotinib - 1056634-68-4 -
Momelotinib Dihydrochloride - 1380317-28-1 -
Monomethylauristatin E - 202590-98-5 -
N-(2-Chloro-4- N hydroxyphenyl)-N'- - 796848-79-8 - cyclopropyl-urea N1-(5-methoxy-4-((4-(1-methyl-1H- indol-3-yl)pyrimidin-2-yl)methyl)-2- - 1421372-67-9 - nitrophenyl)-N1,N2,N2- trimethylethane-1,2-diamine
Nafoxidine - 1847-63-8 -
Nandrolone Base & - 434-22-0 - Derivatives Nandrolone - 62-90-8 - Phenylpropionate
Napabucasin - 83280-65-3 -
Naquotinib - 1448232-80-1 -
Nazartinib - 1508250-71-2 -
Nedisertib - 1637542-33-6 -
Neratinib - 698387-09-6 -
N-Hydroxyurea - 127-07-1 -
Nilotinib - 641571-10-0 -
Nilotinib Hydrochloride - 923288-90-8 -
Nilotinib Hydrochloride - 923288-95-3 - Anhydrous
Nilutamide - 63612-50-0 -
928326-83-4, Nintedanib - - 656247-17-5 Nintedanib Ethanesulfonate - 656247-18-6 - Salt
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 49 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Niraparib - 1038915-60-4 -
AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Nobiletin - 478-01-3 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC , SFDA-GMP, USFDA O ODM201(Darolutamide) - 1297538-32-9 -
Olaparib (AZD2281) - 763113-22-0 -
Osimertinib - 1421373-65-0 -
Osimertinib Mesylate - 1421373-66-1 -
Oxalic Acid - 144-62-7 -
EP,USP Oxaliplatin 61825-94-3 -
P Paclitaxel - 33069-62-4 -
Palbociclib - 571190-30-2 -
Palbociclib Hydrochloride - 827022-32-2 -
Pazopanib - 444731-52-6 -
Pazopanib Hydrochloride - 635702-64-6 -
Pegfilgrastim - 208265-92-3 -
Pemetrexed - 137281-23-3 -
Pemetrexed Disodium - 150399-23-8 -
Pemetrexed Disodium - 357166-29-1 - Heptahydrate Pemetrexed Disodium - 357166-30-4 - Hydrate
Pentostatin - 53910-25-1 -
Pexidartinib Hydrochloride - 1029044-16-3 -
Pixantrone - 144510-96-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 50 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Plerixafor - 110078-46-1 -
Plinabulin - 714272-27-2 -
Pomalidomide - 19171-19-8 EDMF
Ponatinib - 943319-70-8 Tech Pack
Poziotinib - 1092364-38-9 -
Pralatrexate - 146464-95-1 Tech Pack
R Raltitrexed - 112887-68-0 -
Raparixin - 266359-83-5 -
Refametinib - 923032-37-5 -
Regorafenib - 755037-03-7 -
Regorafenib Hydrochloride - 835621-07-3 CGMP, ISO
Relugolix - 737789-87-6 -
Ribociclib - 1211441-98-3 -
Ridaforolimus - 572924-54-0 -
Rituximab IHS 174722-31-7 -
Roblitinib - 1708971-55-4 -
Rociletinib - 1446700-26-0 -
Romidepsin - 128517-07-7 Tech Pack
Rucaparib - 283173-50-2 GMP
Rucaparib Camsylate - 1859053-21-6 -
Rucaparib Phosphate - 459868-92-9 -
Ruxolitinib - 941678-49-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 51 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Ruxolitinib Phosphate - 1092939-17-7 -
S Saracatinib - 379231-04-6 -
Selinexor - 1393477-72-9 ISO
Sorafenib - 284461-73-0 -
Sorafenib Tosylate - 475207-59-1 WC
S-Talazoparib - 1207456-00-5 -
IHS Staurosporin 62996-74-1 -
- Streptozocin 18883-66-4 -
IHS Sunitinib Base 557795-19-4 DMF
Sunitinib D10 - 1126721-82-1 -
Sunitinib Malate - 341031-54-7 -
Sunitinib N-Oxide - 356068-99-0 -
T Tafinlar - 1195768-06-9 -
Talazoparib - 1207456-01-6 -
Tamoxifen - 10540-29-1 -
Tamoxifen Citrate - 54965-24-1 -
Tanzisertib - 899805-25-5 -
Tasquinimod - 254964-60-8 -
Tegafur - 17902-23-7 -
Temozolomide - 85622-93-1 -
Temozolomide Acid - 113942-30-6 -
Temsirolimus - 162635-04-3 GMP, WHO-GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 52 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Thiotepa - 52-24-4 WC
Tipiracil - 183204-72-0 -
Tirapazamine - 27314-97-2 -
- - Tivozanib AV 951 475108-18-0
- - Tofacitinib Base 477600-75-2
IHS Tofacitinib Citrate 540737-29-9 ASMF, USDMF
Topotecan - 123948-87-8 -
Topotecan Hydrochloride - 119413-54-6 -
Toremifene Citrate - 89778-27-8 -
Tozasertib - 639089-54-6 -
Trametinib - 871700-17-3 -
Trilaciclib - 1374743-00-6 -
Tyroserleutide - 138168-48-6 -
V Valrubicin - 56124-62-0 -
Vandetanib - 443913-73-3 -
Varlitinib Ditosylate - 1146629-86-8 -
Veliparib Hydrochloride - 912445-05-7 -
Vemurafenib - 918504-65-1 -
Venetoclax - 1257044-40-8 -
Vineblastine Sulfate Salt - 143-67-9 -
Vinorelbine Ditartrate - 125317-39-7 -
Vismodegib - 879085-55-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 53 API Cancer Management
Product Pharmacopoeia CAS No. Technical Document
Voxtalisib - 934493-76-2 -
VX-11e (ERK 11e) - 896720-20-0 -
Z Zanubrutinib - 1691249-45-2 -
Zoptarelin Doxorubicin - 139570-93-7 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 54 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
A Alizapride - 59338-93-1 ODMF, Tech Pack
Acipimox - 51037-30-3 -
Adenosine BP, EP, USP 58-61-7 GMP
Alagebrium Chloride - 341028-37-3 -
Aliskiren BP, EP, USP 173334-57-1 -
Aliskiren Hemifumarate - 173334-58-2 GMP, WHO GMP
Ambasilide - 83991-25-7 -
Ambrisentan - 177036-94-1 -
Amiloride Hydrochloride BP, EP, USP 17440-83-4 WC
Amiodarone - 1951-25-3 -
Amiodarone Hydrochloride - 199774-82-4 DMF, GMP
Amlodipine Besilate - 111470-99-6 -
Amlodipine Maleate - 88150-47-4 WC
Anacetrapib - 875446-37-0 -
Angiotensin II - 4474-91-3 -
Apabetalone - 1044870-39-4 ISO
Atenolol EP 29122-68-7 WC
Atorvastatin EP, IP, USP 110862-48-1 -
Atorvastatin Calcium - 134523-03-8 - Atorvastatin Calcium EP 344423-98-9 WC Trihydrate Aviptadil Acetate - 40077-57-4 -
Azelnidipine IP, JP 123524-52-7 Tech Pack
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 55 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Azilsartan - 147403-03-0 Tech Pack Azilsartan Medoxemil - 863031-24-7 Potassium Azilsartan Medoxomil - 863031-21-4 Tech Pack
Azimilide Hydrochloride - 149888-94-8 ISO
B Batifiban - 710312-77-9 -
Bemarinone - 92210-43-0 -
Bempedoic Acid - 738606-46-7 -
Benazepril - 86541-75-5 -
Benazepril Hydrochloride - 86541-74-4 CEP, EDMF
Bendipine - 105979-71-7 -
Bendroflumethiazide - 73-48-3 -
Benidipine - 105979-17-7 -
Benidipine Hydrochloride JP 91599-74-5 Tech Pack
Benzafibrate - 41859-67-0 DMF, GMP
Benziodarone - 68-90-6 -
Benzthiazide - 91-33-8 -
Bepotastine Besylate - 190786-44-8 -
Betaxolol Hydrochloride - 63659-19-8 -
Bisoprolol Fumarate - 104344-23-2 -
Bosentan - 147536-97-8 -
Bosentan Monohydrate IHS, USP 157212-55-0 -
Bumetanide - 28395-03-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 56 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Calcium Dobesilate BP, EP 20123-80-2 - C Monohydrate Candesartan - 139481-59-7 -
Candesartan Cilexetil USP 35 145040-37-5 DMF
Cangrelor Base - 163706-06-7 -
Cangrelor Tetrasodium - 163706-36-3 -
Captopril - 62571-86-2 - AFSSAPS (France), ANVISA (Brazil), BfArM (Germany), Cofepris Carteolol Hydrochloride - 51781-21-6 (Mexico), EDQM, ISMS, ISO 9001:2000, OHSAS, PMDA (Japan), TGA (Australia), US FDA Carvedilol BP, EP, IP, USP 72956-09-3 WC
Celiprolol - 56980-93-9 CGMP, QMS
Centatin - 104010-41-5 -
Cetamolol - 34919-98-7 -
Chlorthalidone IP, USP 77-36-1 -
Choline Fenofibrate - 856676-23-8 cGMP
Cilnidipine JP 132203-70-4 DMF
Cinepazide Maleate - 26328-04-1 -
Ciprofibrate - 52214-84-3 -
Clevidipine Butyrate - 167221-71-8 GMP
Clonidine - 4205-90-7 US-FDA
Clonidine Hydrochloride EP, USP 4205-91-8 USDMF
Colestipol Hydrochloride - 37296-80-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 57 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Colsevelam Hydrochloride - 182815-44-7 - AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Cytidine - 65-46-3 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA D Dalcetrapib - 211513-37-0 -
Delapril - 83435-66-9 -
Dexrazoxane - 24584-09-6 -
Diazoxide - 364-98-7 -
Digoxin BP, IP 20830-75-5 - Dihydralazine Sulfate, BP 70175-06-3 - Hydrated Dihydralazine Sulphate BP, EP 7327-87-9 DMF Hydrated Dilazep Hydrochloride JP 35898-87-4 - Hydrate Diltiazem - 42399-41-7 cGMP, GMP
Diltiazem Hydrochloride BP, EP, IP, USP 33286-22-5 WC DL-Ephedrine BP, IP, USP 134-71-4 - Hydrochloride Dobutamine Hydrochloride - 49745-95-1 ISO, SMS, USAC
Dofetilide - 115256-11-6 USDMF
Dorzolamide USP 130693-82-2 -
Doxazosin - 74191-85-8 -
Doxazosin Mesylate BP, EP, IHS, JP, USP 77883-43-3 DMF
Dronedarone - 141626-36-0 Tech Pack SAMPLE, Tech Pack, Dronedarone Hydrochloride - 141625-93-6 USDMF Droxidopa - 23651-95-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 58 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
E Ecallantide - 460738-38-9 GMP, WHO-GMP
Ecastolol - 77695-52-4 -
Efonidipine - 111011-63-3 - Efonidipine Hydrochloride - 111011-76-8 - Ethanolate Enalapril - 75847-73-3 - 1H NMR, CoA, HPLC, Enalapril Maleate - 76095-16-4 Mass, IR Eplerenone - 107724-20-9 -
Epoprostenol Sodium - 61849-14-7 Tech Pack
Eprosartan Mesylate - 144143-96-4 WC
Esmolol Hydrochloride - 81161-17-3 WC
Esuberaprost Sodium - 152695-53-9 -
Ethacrynate Sodium - 6500-81-8 USDMF
Ethacrynic Acid - 58-54-8 USDMF
Etilefrine Hydrochloride - 943-17-9 GMP
Ezetimibe - 163222-33-1 -
F Fasidotril ,98%NLT - 135038-57-2 -
Fasudil - 103745-39-7 -
Fasudil Hydrochloride - 105628-07-7 -
Felodipine BP, EP, IP, USP 72509-76-3 DMF
Fenofibrate - 49562-28-9 1H NMR, CoA, HPLC, Fenofibricacid - 47017-89-0 Mass, IR Fimasartan - 247257-48-3
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 59 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Fimasartan Potassium - 1020110-23-9 - Trihydrate Finerenone - 1050477-31-0 -
Flecainide Acetate - 54143-55-4 CEP, EDMF, USDMF
Fluvastatin - 93957-54-1 -
Fluvastatin Sodium USP 93957-55-2 Tech Pack
Fosinopril - 98048-97-6 ISO9001
Fosinopril Sodium - 88889-14-9 Tech Pack
Furosemide - 54-31-9 -
G Gemfibrozil EP, USP 25812-30-0 WC
Guancydine - 1113-10-6 -
H Hydralazine Hydrochloride - 304-20-1 -
Hydrochlorothiazide - 58-93-5 -
I Ibutilide Fumarate - 122647-32-9 -
Icatibant - 138614-30-9 -
Iganidipine - 119687-33-1 -
Imidapril - 89371-37-9 -
Imidapril Hydrochloride - 89396-94-1 DMF, USDMF
Indapamide EP 26807-65-8 WC
Irbesartan EP 7.0, USP 37 138402-11-6 COS, DMF, GMP
Isoproterenol Hydrochloride - 7683-59-2 -
Isosorbide - 652-67-5 -
Isosorbide-5-mononitrate - 16051-77-7 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 60 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Isoxsuprine Hydrochloride - 579-56-6 -
Ivabradine - 155974-00-8 -
Ivabradine Hydrochloride - 148849-67-6 -
K Ketanserin - 74050-98-9 -
Ketanserin Tartrate - 83846-83-7 -
L Labetalol - 36894-69-6 -
Labetalol Hydrochloride BP, EP, IP, USP 32780-64-6 CEP, USDMF, WC
Lacidipine BP 103890-78-4
Lanthanum Carbonate - 54451-24-0 DMF, USDMF Lanthanum Carbonate - 929207-29-4 WC Dihydrate L-Arginine Malate - 41989-03-1 -
Lercanidipine - 100427-26-7 -
Levamlodipine - 103129-82-4 -
Levobunolol Hydrochloride - 27912-14-7 -
Levosimendan - 141505-33-1 -
Lisinopril - 83915-83-7 CEP, EDMF
Lofexidine - 31036-80-3 -
Lomitapide - 182431-12-5 -
Losartan Potassium USP 35 124750-99-8 -
Lovastatin USP 35 75330-75-5 DMF, GMP
M Macitentan - 441798-33-0 - AFSSAPS (France), ANVISA (Brazil), BfArM Manidipine Dihydrochloride - 89226-75-5 (Germany), Cofepris US FDA
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 61 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Metaraminol Bitartate - 33402-03-8 -
Methyldopa - 41372-08-1 -
Metolazone - 17560-51-9 - 1H NMR, CoA, HPLC, Metoprolol - 37350-58-6 Mass, IR Metoprolol Succinate - 98418-47-4 -
Metoprolol Tartrate - 56392-17-7 -
Mexiletine Hydrochloride - 5370-01-4 -
Midodrine Hydrochloride - 43218-56-0 US-FDA
Mildronate - 86426-17-7 -
Milrinone - 78415-72-2 -
Modecainide - 81329-71-7 -
Moexipril Hydrochlodrde - 82586-52-5 -
Molsidomine BP, EP, USP 25717-80-0 GMP
Moxonidine EP 75438-57-2 -
Moxonidine Hydrochloride - 75438-58-3 - N-(5-Chloropyridin-2-yl)oxalaMic - 349125-08-2 - N acid ethyl ester Nadolol - 42200-33-9 USDMF
Nalfurafine Hydrochloride - 152658-17-8 -
Nebivolol - 99200-09-6 -
Nebivolol Hydrochloride - 152520-56-4 -
Nesiritide - 124584-08-3 -
Nicardipine - 55985-32-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 62 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Nicardipine Hydrochloride USP 54527-84-3 DMF
Nicorandil IP, JP 65141-46-0 DMF
Nifedipine - 21829-25-4 - 144689-24-7, Olmesartan - - O 144689-78-1 Olmesartan Medoxomil - 144689-63-4 -
Otenzepad - 102394-31-0 -
Oxyfedrine Hydrochloride - 15687-41-9 -
Oxymatrine - 16837-52-8 -
P Pamabrom - 606-04-2 -
Pentoxifylline BP, EP, USP 6493-05-6 DMF, CEP, WC
Perindopril EP 107133-36-8 WC Phenoxybenzamine USP 63-92-3 DMF 031746 Hydrochloride Phentolamine Mesylate - 65-28-1 -
Phthaloyl Amlodipine - 88150-62-3 CGMP, GMP
Pindolol - 13523-86-9 -
Piroxicam-beta-cyclodextrin - 96684-39-8 -
Pitavastatin - 147511-69-1 -
Pitavastatin Calcium - 147526-32-7 WC
Pravastatin EP 81093-37-0 -
Pravastatin Sodium - 81131-70-6 GMP
Prazosin - 19216-56-9 -
Prazosin Hydrochloride BP, EP, IP, USP 19237-84-4 DMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 63 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Propafenone - 54063-53-5 -
Propafenone Hydrochloride - 34183-22-7 -
Propanolol - 525-66-6 - 3506-09-0, Propranolol Hydrochloride USP - 525-66-6 Prostaglandin E1 - 745-65-3 -
Q Quercetin - 117-39-5 -
Quercetin Dihydrate - 6151-25-3 -
Quinalapril Hydrochloride USP 82586-55-8 WC
R Ramatroban - 116649-85-5 -
Ramipril - 87333-19-5 -
Ranolazine - 95635-55-5 -
Ranolazine Base - 142387-99-3 CGMP
Raubasine - 483-04-5
Regadenoson - 313348-27-5 Reserpine (Rauwolfia - 50-55-5 Vomitoria Extract) Resveratrol - 501-36-0
Riociguat - 625115-55-1 -
Ripasudil - 223645-67-8 -
Rosuvastatin - 147098-18-8 -
Rosuvastatin Calcium EP, IP 147098-20-2 -
S S-acetyl-L-Glutathione - 3054-47-5 -
Sacubitril - 149709-62-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 64 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Sacubitril Calcium Salt - 1369773-39-6 -
Sacubitril / Valsartan - 936623-90-4 -
Scutellarin - 27740-01-8 -
Selexipag - 475086-01-2 -
Sematilide - 101526-83-4 -
Silodosin - 160970-54-7 -
Simvastatin - 79902-63-9 -
Sodium Dichloroacetate - 2156-56-1 -
Sodium Nitroprusside EP, USP 14402-89-2 ASMF, USDMF
Sodium Phenyl Butyrate 1716-12-17 -
Sotalol Hydrochloride 959-24-0 -
Spironolactone - 52-01-7 -
T Talinolol - 57460-41-0 EDMF
Telmisartan - 144701-48-4 -
Telmisartan Sodium - 515815-47-1 -
Teludipine Hydrochloride - 108700-03-4 -
Temocapril - 111902-57-9 -
Temocapril Hydrochloride - 110221-44-8 -
Tiapamil Hydrochloride - 57010-32-9 - Timolol Hemihydrate & 91524-16-2, - - Hydrogen Maleate 26921-17-5 Tolazoline Hydrochloride - 59-97-2 -
Tolvaptan - 150683-30-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 65 API Cardiovascular
Product Pharmacopoeia CAS No. Technical Document
Torasemide - 56211-40-6 -
Trandolapril EP, USP 87679-37-6 Tech Pack, USDMF, WC
Trichlormethiazide JP 133-67-5 -
Trimetazidine - 5011-34-7 - Trimetazidine - 13171-25-0 - Dihydrochloride AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Troxerutine - 7085-55-4 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA V Valsartan - 137862-53-4 -
Verapamil EP, IP, USP 52-53-9 -
Verapamil Hydrochloride - 23313-68-0 -
Vericiguat - 1350653-20-1 -
Vorapaxar - 618385-01-6 -
Vorapaxar Sulfate - 705260-08-8 -
X Xipamide - 14293-44-8 -
Z Zofenopril - 81872-10-8 USDMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 66 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
A Acepifylline - 18833-13-12 -
Adiphenine Hydrochloride - 50-42-0 -
Adrafinil - 63547-13-7 GMP
Agomelatine - 138112-76-2 DMF
Aligeron - 70713-45-0 -
Alimemazine Tartrate BP, EP 4330-99-8 -
Allopregnanolone - 516-55-2 -
Allyl Iso-Propyl Acetyl Urea - 528-92-7 -
Alniditan - 152317-89-0 -
Aloradine - 23062-06-8 -
Alosetron Hydrochloride - 122852-69-1 USDMF
Alvameline - 120241-31-8 -
Amantadine Hydrochloride - 768-94-5 -
Amisulpride - 71675-85-9 -
Amitafadine Hydrochloride - 410074-74-7 -
Amitriptyline BP, EP, USP 50-48-6 JDMF, USDMF
Amitriptyline Hydrochloride - 549-18-8 CGMP
Amitriptyline N Oxide - 4317-14-0 EDMF
Amoxapine BP, EP, IP, JP, USP 14028-44-5 -
Aniracetam - 72432-10-1 -
Apomorphine Hydrochloride EP, USP 41372-20-7 DMF
Aptiganel - 137159-92-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 67 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Arimoclomol Maleate - 289893-26-1 -
Aripiprazole - 129722-12-9 -
Aripiprazole Lauroxil - 1259305-29-7 -
Armodafinil - 112111-43-0 -
Articaine - 23964-57-0 -
Asenapine - 65576-45-6 -
Asenapine Maleate - 85650-56-2 -
Aticaprant - 1174130-61-0 -
Atomoxetine Hydrochloride - 82248-59-7 -
B Baicalin - 21967-41-9 - 14919-77-8, Benserazide Hydrochloride - - 14046-64-1 Benzilic Acid - 76-93-7 -
Benzocaine - 94-09-7 -
Benztropine Mesylate - 132-17-2 -
Betahistine - 5638-76-6 CEP, EDMF
Betahistine Dihydrochloride BP, EP, IP, USP 5579-84-0 CEP, TDMF, WC
Betahistine Mesylate EP, IP, JP 54856-23-4 Tech Pack
Betaine Hydrochloride - 590-46-5 -
Biperiden - 514-65-8 -
Biperiden Hydrochloride BP, EP, USP 1235-82-1 DMF
Blonanserin - 132810-10-7 -
Brexpiprazole - 913611-97-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 68 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Brivaracetam - 357336-20-0 -
Bromazepam - 1812-30-2 -
Bromisoval - 496-67-3 GMP
Bupivacaine - 2180-92-9 -
Bupivacaine Hydrochloride - 14252-80-3 -
Bupropion USP 34911-55-2 USDMF
Bupropion Hydrobromide - 905818-69-1 -
Bupropion Hydrochloride - 31677-93-7 -
Buspirone EP, USP 36505-84-7 USDMF
Buspirone Hydrochloride - 33386-08-2 GMP
C Cabergoline - 81409-90-7 -
Cannabidiol - 13956-29-1 -
Carbamazepine - 298-46-4 -
Carbidopa EP, USP 28860-95-9 -
Cariprazine - 839712-12-8 -
Cariprazine Hydrochloride - 1083076-69-0 Tech Pack
Carmustine - 154-93-8 GMP, WHO-GMP
Centpropazine - 91315-34-3 -
Cevimeline Hydrochloride - 107233-08-9 -
Chloral Hydrate - 302-17-0 -
Chlorbutanol - 57-15-8 cGMP
Chlordiazepoxide BP, EP, IP, USP 58-25-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 69 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Chlordiazepoxide - 438-41-5 - Hydrochloride Chlorobutanol BP, EP, USP 6001-64--5 TDS
Chlorpromazine - 50-53-3 GMP, ISO Chlorpromazine BP, EP, IP, USP 69-09-0 - Hydrochloride Chlorprothixene BP, EP 6469-93-8 - Hydrochloride Cinnarizine BP, EP 298-57-7 -
Citalopram Hydrobromide - 59729‐32‐7 -
Citicoline - 987-78-0 -
Citicoline Sodium - 33818-15-4 -
Clobazam - 22316-47-8 -
Clomethiazole - 533-45-9 DMF
Clomethiazole Edisilate - 1867-58-9 DMF
Clomipramine EP 303-49-1 CEP, EDMF, WC Clomipramine - 17321-77-6 - Hydrochloride Clonazepam EP, USP 1622-61-3 Tech Pack
Clozapine USP 5786-21-0 -
Cyamemazine - 3546-03-0 -
D Dapoxetine Base - 119356-77-3 -
Dapoxetine Hydrochloride - 129938-20-1 WC
Deramciclane - 120444-71-5 -
Desipramine BP, USP 50-47-5 - Desvenlafaxine - 300827-87-6 - Hydrochloride
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 70 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Desvenlafaxine Succinate - 386750-22-7 -
Dexmedetomidine - 113775-47-6 USDMF Dexmedetomidine - 145108-58-3 - Hydrochloride Dexmethylphenidate IHS 19262-68-1 Tech Pack Hydrochloride Diazepam BP, EP, IP, USP 439-14-5 EDMF
Dibucaine BP, USP 85-79-0 -
Dibucaine Hydrochloride BP, EP, USP 61-12-1 ODMF
Divalproex Sodium - 76584-70-8 -
Donepezil - 120014-06-4 - 110119-84-1, Donepezil Hydrochloride - - 120011-70-3 Dopamine Hydrochloride - 62-31-7 - DMF, GMP, ISO, WHO- Dothiepin - 113-53-1 GMP Dothiepin Hydrochloride - 897-15-4 EDMF
Doxepin Hydrochloride - 1229-29-4 CGMP
Droperidol - 548-73-2 -
Duloxetine - 116539-59-4 -
Duloxetine Hydrochloride - 136434-34-9 -
E Ecopipam - 112108-07-7 -
Entacapone - 130929-57-6 -
Escitalopram Oxalate IP, USP 219861-08-2 WC
Esketamine Hydrochloride - 33643-47-9 -
Eslicarbazepine Acetate - 236395-14-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 71 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Estazolam - 29975-16-4 -
Eszopiclone - 138792-47-2 WC
Ethosuximide - 77-67-8 -
Etizolam - 40054-69-1 -
Etomidate - 33125-97-2 GMP
F Fasoracetam - 110958-19-5 -
Felbamate - 25451-15-4 -
Fenobam - 57653-26-6 -
Fladrafinil CRL-40,941 - 90212-80-9 GMP, WHO-GMP
Fludiazepam - 3900-31-0 -
Flumazenil - 78755-81-4 -
Flunarizine Dihydrochloride - 30484-77-6 CEP, USDMF
Fluoxetine - 54910-89-3 - CEP, K-DMF, TDMF, TGA, Fluoxetine Hydrochloride BP, EP, USP 56296-78-7 TPD Canada, WC Flupentixol Decanoate - 30909-51-4 -
Flupentixol Dihydrochloride BP, EP 2413-38-9 WC
Fluphenazine - 69-23-8 -
Fluphenazine Decanoate BP, EP, IP, USP 5002-47-1 - Fluphenazine - 146-56-5 - Hydrochloride Fluvoxamine Maleate BP, EP, IP, JP, USP 61718-82-9 -
Fosphenytoin Sodium - 92134-98-0 -
G Gabapentin - 60142-96-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 72 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Gabapentin Enacarbil - 478296-72-9 -
Gabapentin Hydrochloride - 60142-95-2 DMF, GMP
Galantamine Hydrobromide - 1953-4-4 - AHF-Halal, CNAS(ISO17025), Galanthamine - 357-70-0 HACCP, NSF-cGMP, OU- Kosher, QC , SFDA-GMP, USFDA Glatiramer Acetate - 147245-92-9 -
Guanfacine Hydrochloride USP 29110-48-3 WC
H Haloperidol - 52-86-8 -
Haloperidol Decanoate - 74050-97-8 -
I Idebenone - 58186-27-9 -
Iloperidone IHS, IP 133454-47-4 Tech Pack DMF, GMP, ISO, WHO- Imipramine - 50-49-7 GMP Imipramine Hydrochloride BP, EP, IP, USP 113-52-0 USDMF, WC
Imipramine Pamoate - 10075-24-8 USDMF
Intepirdine - 607742-69-8 -
Isocarboxazid IP, USP 59-63-2 -
K Ketamine Hydrochloride BP, EP, USP 1867-66-9 CEP, EDMF, USDMF, WC
Ketocaine - 1092-46-2 -
L Lacosamide - 175481-36-4 -
Lamotrigine - 84057-84-1 -
Laquinimod - 248281-84-7 -
Lemborexant - 1369764-02-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 73 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Levetiracetam - 102767-28-2 -
Levobupivacaine - 27262-48-2 - Hydrochloride AHF-Halal, CNAS(ISO17025), Levodopa - 59-92-7 HACCP, NSF-cGMP, OU- Kosher, QC, SFDA-GMP, USFDA Levodopa Methyl Ester - 1421-65-4 - Hydrochloride
Levomepromazine Maleate EP, JP 7104-38-3 WC
Levomilnacipran - 96847-55-1 DMF
Levomilnacipran - 175131-60-9 ODMF, Tech Pack Hydrochloride Levophacetoperane - 23257-56-9 - Hydrochloride
Levosulpiride - 23672-07-3 -
Lidocaine Base - 137-58-6 -
Lidocaine Base / - 6108-05-0 - Hydrochloride Lidocaine Hydrochloride - 73-78-9 -
Lisdexamfetamine - 608137-33-3 -
Lithium Carbonate - 554-13-2 -
Lomerizine Hydrochloride - 101477-54-7 -
Loprazolam - 61197-93-1 -
Lorazepam - 846-49-1 -
Loxapine Succinate - 27833-64-3 -
Lumateperone - 313368-91-1 -
Lurasidone - 367514-87-2 -
Lurasidone Hydrochloride IHS 367514-88-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 74 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Lysergic Acid - 82-58-6 -
M Matrine - 519-02-8 -
Meclonazepam - 58662-84-3 -
Melitracen - 5118-29-6 -
Melitracen Hydrochloride - 10563-70-9 -
41100-52-1, Memantine Hydrochloride - WC 51052-62-1
Meprobamate - 57-53-4 -
Methylphenidate - 113-45-1 -
Methylphenidate BP, EP, USP 298-59-9 WC Hydrochloride Mianserin Hydrochloride - 21535-47-7 -
Midazolam - 59467-64-0 -
Milnacipran Hydrochloride IHS 101152-94-7 ASMF
61337-67-5, 1H NMR, CoA, HPLC, Mirtazapine USP 85650-52-8 Mass, IR
Modafinil - 68693-11-8 -
Monomethyl Fumarate - 1577222-14-0 -
N Nalmefene Hydrochloride - 58895-64-10 -
Naloxone Hydrochloride EP, USP 51481-60-8 -
Naltrexone Hydochloride - 16676-29-2 -
Naratriptan Hydrochloride USP 54527-84-3 DMF, EDMF, WC
Naratriptan Hydrochloride - 143388-64-1 -
Nefazodone - 83366-66-9 -
Nefiracetam - 77191-36-7 GMP, WHO-GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 75 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document AHF-Halal, CNAS(ISO17025), Nicergoline - 27848-84-6 HACCP, NSF-cGMP, OU- Kosher, QC, SFDA-GMP, USFDA
Nicotine - 54-11-5 -
Nicotine Base EP, USP 22083-74-5 -
Nicotine Bitartrate - 6019-06-3 - Dihydrate
Nitrazepam - 146-22-5 -
Nitroxazepine - 47439-36-1 -
Nitroxazepine - 16398-39-3 - Hydrochloride
Nordazepam - 1088-11-5 -
Nortriptyline Hydrochloride BP, EP, IP, USP 894-71-3 EDMF, J-DMF, USDMF
O O-Desmethyl Venlafaxine - 93413-62-8 -
Olanzapine - 132539-06-1 -
Opipramol Dihydrochloride - 909-39-7 EDMF
Osilodrostat - 928134-65-0 ISO
Oxazepam BP, EP, IP, USP 604-75-1 WC
Oxcarbazepine IP, USP 28721-07-5 -
Ozanimod - 1306760-87-1 -
P Paliperidone IHS, USP 144598-75-4 Tech Pack
Palladium Chloride - 7647-10-1 -
Paroxetine - 61869-08-7 -
Paroxetine Hydrochloride - 78246-49-8 -
Paroxetine Hydrochloride DMF 110429-35-1 - Hemihydrate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 76 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Pentazocine / BP, USP 64024-15-3 USFDA Pentazocin Hydrochloride
Perampanel - 380917-97-5 -
Perazine Dimalonate - 14777-25-4 -
Perazine Maleate BP, IP, USP 84-97-9 -
Phenibut - 1078-21-3 -
Phenobarbital - 50-06-6 -
Phenobarbital Sodium - 57-30-7 -
Phenothiazine - 92-84-2 -
Phenytoin - 57-41-0 -
Phenytoin Sodium - 630-93-3 -
Phosphatidylcholine - 97281-47-5 -
Picrotoxin - 124-87-8 -
Pimavanserin - 706779-91-1 -
Piperacetazine - 3819-00-9 -
Pipotiazine Base - 39860-99-6 -
Piracetam - 7491-74-9 -
Piribedil - 3605-1-4 -
Ponesimod - 854107-55-4 -
Pramepexole - 104632-26-0 - Pramipexole EP, USP 104632-25-9 USDMF Dihydrochloride
Prazepam - 2955-38-6 WC
Pregabalin - 148553-50-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 77 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Prifinium Bromide - 4630-95-9 EDMF
Primidone BP, EP, USP 125-33-7 COS, USDMF, WC
Procyclidine BP, IP 77-37-2 -
Propiomazine Maleate - 3568-23-8 USDMF
Q Quetiapine - 111974-69-7 -
Quetiapine Fumarate - 111974-72-2 JDMF, USDMF, WC
Quetiapine Sulfoxide - 329216-63-9 ISO9001
R Ramelteon - 196597-26-9 DMF, GMP
Rapestinel - 117928-94-6 ISO
Rasagaline - 1875-50-9 -
Rasagiline Mesylate - 161735-79-1 -
Rasagiline Tartrate - 136236‐52‐7 -
Remimazolam - 308242-62-8 -
Remimazolam Besylate - 1001415-66-2 -
Retigabine - 150812-12-7 -
Rhodiola Rosea P.E. - 10338-51-9 ISO
Riluzole - 1744-22-5 -
Risperidone BP, EP, USP 106266-06-2 -
Risperidone N-Oxide EP 832747-55-4 ISO9001
Rivastigmine EP, USP 123441-03-2 WC
Rivastigmine Tartrate EP, USP 129101-54-8 WC
Rizatriptan Benzoate EP, USP 145202-66-0 CEP, EDMF, USDMF, WC
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 78 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Ropinirole Hydrochloride - 91374-20-8 -
125572-93-2, Rotigotine - - 99755-59-6
Rufinamide - 106308-44-5
Rupatadine Fumarate EP 182349-12-8 CEP, EDMF
S Safinamide Mesylate IHS 202825-46-5 -
Sarcosine - 107-97-1 -
Sarizotan Hydrochloride - 195068-07-6 -
Selegiline Hydrochloride - 14611-52-0 DMF
Selumetinib - 606143-52-6 ISO
Selumetinib Sulfate - 943332-08-9 ISO
Sertindole - 106516-24-9 -
Sertraline - 79617-96-2 -
79617-96-2, Sertraline Hydrochloride - - 79559-97-0
Sodium Oxybate - 502-85-2 EDMF, WC
Sodium Valproate - 1069-66-5 -
Stiripentol - 49763-96-4 -
Sugammadex - 343306-79-6 -
Sugammadex Sodium IHS 343306-71-8 -
Sulpiride BP, EP, JP 15676-16-1 -
Sumatriptan - 103628-46-2 -
Sumatriptan Succinate - 103628-48-4 -
Suvorexant - 1030377-33-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 79 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
T Tacrine - 321-64-2 -
Tafamidis - 594839-88-0 -
Tandospirone Citrate - 112457-95-1 ODMF, Tech Pack
Tasimelteon - 609799-22-6 -
Temazepam - 846-50-4 -
Tetrabenazine - 58-46-8 -
Tetracaine Base - 94-24-6 EDMF, USDMF
Tetracaine Hydrochloride BP, USP 136-47-0 -
Tetrazepam BP, EP 10379-14-3 WC
Thiopental Sodium BP 71-73-8 -
Thioproperazine Mesylate - 2347-80-0 -
Thioridazine Hydrochloride BP, USP 130-61-0 -
Thiothixene - 5591-45-7 -
Tianeptine Sodium - 30123-17-2 -
Tofisopam IHS, JP 22345-47-7 GMP
Topiramate USP 97240-79-4 WC
Tozadenant - 870070-55-6 ISO
Trazodone - 19794-93-5 -
Trazodone Hydrochloride - 25332-39-2 -
Triazolam - 28911-01-5 -
Triclofos Sodium BP 7246-20-0 DMF CTD, USFDA
Triflubazam - 22365-40-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 80 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Trifluoperazine BP, EP 440-17-5 - Hydrochloride
Trihexyphenidyl BP, EP, IP, USP 52-49-3 ODMF
Trihexyphenidyl 58947-95-8, - - Hydrochloride 144-11-6
Trimipramine Maleate BP, EP 521-78-8 EDMF, WC
Trimipramine Mesylate BP 25332-13-2 EDMF, WC
U Ubrogepant - 1374248-77-7 -
V Valbenazine - 1025504-45-3 -
Valbenazine Tosylate IHS 1639208-54-0 -
Valproic Acid - 99-66-1 -
Varenicline Base - 249296-44-4 US DMF
Varenicline Tartarate - 375815-87-5 US DMF
Venlafaxine USP 93413-69-5 ISO9001
Venlafaxine Hydrochloride - 99300-78-4 -
Vigabatrin - 60643-86-9 -
Vilazodone Hydrochloride - 163521-08-2 -
Vildagliptin - 274901-16-5 -
AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Vincamine - 1617-90-9 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA
Vinpocetine EP 42971-09-5 -
Vortioxetine - 508233-74-7 -
X Xylamidine - 6443-50-1 -
Xylazine Base EP 7361-61-7 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 81 API Central Nervous System
Product Pharmacopoeia CAS No. Technical Document
Z Zaleplon - 151319-34-5 -
Ziprasidone Base EP 146939-27-7 CEP
Ziprasidone Hydrochloride - 122883-93-6 CGMP
Zolantidine - 104076-38-2 -
Zolmitriptan - 139264-17-8 -
Zolpidem L- (+)-Hemitartrate - 99294-93-6 -
Zolpidem Tartrate - 99294-93-6 CEP, EDMF, USDMF
Zopiclone BP, EP 43200-80-2 COS, EDMF, USDMF, WC
Zotepine In-House 26615-21-4 GMP
Zuclopenthixol - 53772-83-1 -
Zuclopenthixol Acetate - 85721-05-7 -
Zuclopenthixol Deconate BP, EP 64053-00-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 82 API Dermatology
Product Pharmacopoeia CAS No. Technical Document
A Abrocitinib PF-04965842 - 1622902-68-4 -
Acitretin - 55079-83-9 -
Adapalene EP, USP 106685-40-9 -
Allantoin IP, USP 97-59-6 -
Apremilast - 608141-41-9 -
Azelaic Acid - 123-99-9 -
C Carbamide Peroxide USP 124-43-6 -
Chlorophyllin - 11006-34-1 - Chlortetracycline - 64-72-2 ISO Hydrochloride Clocortolone Caproate - 4891-71-8 -
Clocortolone Pivalate - 34097-16-0 USDMF
Crisaborole IHS 906673-24-3 DMF
Crotamiton - 483-63-6 -
D Decapeptide - 137665-91-9 -
Dequalinum Chloride - 522-51-0 -
Desoximetasone BP, EP, IP, JP, USP 382-67-2 -
Dyclonine Hydrochloride - 536-43-6 -
E Eflornithine Hydrochloride EP, USP 67037-37-0 DMF Eflornithine Hydrochloride IHS 96020-91-6 - Monohydrate AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Esculetin - 305-01-1 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC , SFDA-GMP, USFDA H Hydroquinone - 123-31-9 ISO
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 83 API Dermatology
Product Pharmacopoeia CAS No. Technical Document
I Imiquimod - 99011-02-6 DMF, WC
M Minoxidil EP, USP 38304-91-5 WC
Minoxidil Sulphate - 83701-22-8 GMP
P PAC 14028 - 1005168-10-4 -
R Refined Glycerine BP, CP 56-81-5 -
Resorcinol - 108-46-3 -
Ricinoleic Acid (Liquid) - 141-22-0 -
S Salicyclic Acid - 69-72-7 -
Sarecycline Hydrochloride - 1035979-44-2 - AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Sericoside - 55306-04-2 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA Siponimod - 1234627-85-0 -
Squaric Acid - 2892-51-5 -
T Tacalcitol - 57333-96-7 -
Tazarotene - 118292-40-3 -
Tretinoin USP 34 302-79-4 -
U Urea BP, IP 57-13-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 84 API Diabetes Management
Product Pharmacopoeia CAS No. Technical Document
A Acarbose - 56180-94-0 - - Aegeline 456-12-2 - - Alogliptin 850649-61-5 - - Alogliptin Benzoate 850649-62-6 - - Anagliptin 739366-20-2 - - C Canagliflozin 842133-18-0 - - Canagliflozin Hemihydrate 928672-86-0 -
Chlorpropamide BP, EP, IP, USP 94-20-2 -
D Dapagliflozin - 461432-26-8 - Dapagliflozin Propanediol - 960404-48-2 - Monohydrate Dulaglutide - 923950-08-7 GMP, WHO GMP
E Elafibranor - 923978-27-2 ISO
Empagliflozin - 864070-44-0 - Sample, Tech Pack, Emtricitabine - 143491-57-0 USDMF, WC Epalrestat - 82159-09-9 .Tech, GMP 1210344-572, Ertugliflozin - - 1210344-83-4 Exenatide - 141732-76-5 -
F Fasiglifam - 1000413-31-1 -
G Glibenclamide/Glyburide - 10238-21-8 -
Gliclazide - 21187-98-4 -
Glimepiride USP 34 93479-97-1 -
Glipizide - 29094-61-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 85 API Diabetes Management
Product Pharmacopoeia CAS No. Technical Document
Glucagon Hydrochloride - 16941-32-5 -
Gosogliptin - 869490-23-3 -
Gosogliptin Hydrochloride - 869490-47-1 -
I Ipragliflozin - 761423-87-4 -
Ipragliflozin L-proline - 951382-34-6 -
L Linagliptin - 668270-12-0 -
Liraglutide - 204556-20-2 -
Liraglutide Acetate - 204656-20-2 -
Lixisenatide - 320367-13-3 GMP, WHO GMP
Luseogliflozin - 898537-18-3 -
M Metformin - 657-24-9 -
Metformin Glycinate - 121369-64-0 -
Metformin Hydrochloride - 1115-70-4 -
Miglitol - 72432-03-2 -
N Nateglinide BP, EP, IP, USP 105816-04-4 WC
O Omarigliptin - 1226781-44-7 -
P Pioglitazone - 105355-27-9 -
Pioglitazone Hydrochloride - 112529-15-4 -
Pitressin - 11000-17-2 -
Potassium Acetate - 127-08-2 -
Pramlintide - 151126-32-8 -
Pramlintide Acetate - 196078-30-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 86 API Diabetes Management
Product Pharmacopoeia CAS No. Technical Document
R Ranirestat - 147254-64-6 -
Reglitazar - 170861-63-9 -
Remogliflozin Etabonate - 442201-24-3 ODMF, Tech Pack
Repaglidine - 135062-02-1 -
Repaglinide EP, USP 108157-52-4 CEP, USDMF
Rosiglitazone Hydrochloride - 302543-62-0 -
Rosiglitazone Maleate USP 155141-29-0 DMF, USDMF
S Saxagliptin - 361442-04-8 -
Saxagliptin Hydrate - 945667-22-1 -
Saxagliptin Hydrochloride - 709031-78-7 - Saxagliptin Hydrochloride - 1370409-28-1 - Monohydrate Semaglutide - 910463-68-2 -
Sequoyitol - 523-92-2 -
Sergliflozin Etabonate - 408504-26-7 -
Sitagliptin - 486460-32-6 -
Sitagliptin Hydrochloride - 486460-32-6. DMF
Sitagliptin Monohydrochloride - 486459-71-6 - cGMP, GMP, ISO, Sitagliptin Phosphate - 654671-78-0 USFDA Sitagliptin Phosphate - 654671-77-9 - Monohydrate Sotagliflozin - 1018899-04-1 ISO
T Teneligliptin - 760937-92-6 - Teneligliptin Hemipenta JP 906093-29-6 Tech Pack Hydrobromide
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 87 API Diabetes Management
Product Pharmacopoeia CAS No. Technical Document
Teneligliptin Hydrobromide IHS 1572583-29-9 - Hydrate Tofogliflozin - 903565-83-3 ODMF, Tech Pack
Tofogliflozin Hydrate (1:1) - 1201913-82-7 -
Tolazamide - 1156-19-0 -
Tolbutamide BP, USP 64-77-7 -
Trelagliptin - 865759-25-7 -
Trelagliptin Succinate - 1029877-94-8 -
V Vanadyl Sulfate - 123334-20-3 -
Vasopressin - 9034-50-8 GMP, WHO-GMP
Voglibose - 83480-29-9 -
X Xylitol - 87-99-0 DMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 88 API Erectile Dysfunction
Product Pharmacopoeia CAS No. Technical Document
A Avanafil - 330784-47-9 -
B PT141 Bremelanotide) - 189691-06-3 -
S Sildenafil - 139755-83-2 -
Sildenafil Citrate BP, EP, USP 171599-83-0 DMF, CEP, WC 1H NMR, CoA, HPLC, Tadalafil - 171596-29-5 T Mass, IR U Udenafil - 268203-93-6 -
V Vardenafil - 224785-90-4 DMF
Vardenafil Hydrochloride EP 224785-91-5 -
Y Yohimbine Hydrochloride - 65-19-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 89 API Gastrointestinal
Product Pharmacopoeia CAS No. Technical Document
A Alvimopan - 156053-89-3 -
B Balsalazide - 80573-04-2 ISO9001
Bencianol - 85443-48-7 -
Bismuth Citrate USP 813-93-4 -
Bismuth Subcarbonate BP, EP, USP 5892-10-4 -
Bismuth Subnitrate BP, EP, JP, USP 1304-85-4 -
C Camylofine Dihydrocloride IHS 5892-41-1 -
Carotegrast Methyl - 401905-67-7 -
Cimetropium Bromide - 51598-60-8 GLP, GMP, ISO
Cinitapride Hydrogen Tartrate EP, IHS, JP 66564-14-5 GMP
Cisapride - 260779-88-2 cGMP, GMP
Cisapride Monohydrate BP, EP 81098-60-4 DMF, GMP, ISO, WHO GMP
Clidinium Bromide USP 3485-62-9 USDMF
D Dexloxiglumide - 119817-90-2 ISO
Dicyclomine Hydrochloride BP, USP 67-92-5 DMF, ISO, WHO GMP
Diosmin BP, EP, IP, USP 520-27-4 -
Diphenoxylate Hydrochloride BP, EP, USP 3810-80-8 -
Docusate Sodium BP, EP, USP 577-11-7 EDMF
Drotaverine - 14009-24-6 -
Drotaverine Hydrochloride - 985-12-6 DMF
Dulcitol BP 608-66-2 -
E Elobixibat - 439087-18-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 90 API Gastrointestinal
Product Pharmacopoeia CAS No. Technical Document
Eluxadoline - 864821-90-9 -
Eluxadoline Dihydrochloride - 864825-13-8 -
F Fenpiverinium Bromide - 125-60-0 EDMF, WC
Fomepizole - 7554-65-6 -
Fomepizole Sulfate - 123799-93-9 -
G Glycopyrronium Bromide - 51186-83-5 -
Glycopyrrolate - 596-51-0 DMF
H Hyocine-N-Butyl Bromide - 149-64-4 -
Hyosciamine Sulphate - 620-61-1 GLP, GMP, ISO
Hyoscyamine Sulphate BP, EP, IP, USP 6835-16-1 WC
I Isopropamide Iodide - 71-81-8 -
L Lactitol - 585-86-4 -
Lactulose - 4618-18-2 -
Linaclotide - 851119-59-2 -
Linaclotide Acetate - 851199-60-5 -
Loperamide Hydrochloride - 34552-83-5 -
Lubiprostone BP, EP, USP 136790-76-6 GMP
M Mebeverine - 3625-06-7 -
Mebeverine Hydrochloride IH 2753-45-9 -
Mesalamine & Mesalazine BP, EP, USP 89-57-6 -
Metadoxine - 74536-44-0 ODMF, Tech Pack
Metoclopramide BP 364-62-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 91 API Gastrointestinal
Product Pharmacopoeia CAS No. Technical Document
Metoclopramide Base - 364-62-625 -
Metoclopramide Hydrochloride BP, EP, USP, JP 54143-57-6 -
Misoprostol - 59122-46-2 -
Misoprostol 1% dispersion in HPMC - - -
Mosapride Citrate - 112885-42-4 USDMF
O Olsalazine Sodium - 6054-98-4 USDMF
Otilonium Bromide - 26095-59-0 -
P Pancreatin - 8049-47-6 -
Papaverine Hydrochloride USP 61-25-6 -
Pepsin - 9001-75-6 -
Pinaverium Bromide - 53251-94-8 -
Plecanatide - 467426-54-6 -
Polapre Zinc - 107667-60-7 Tech Pack
Prucalopride Succinate - 179474-85-2 DMF, Tech Pack
R Racecadotril EP, USP 81110-73-8 -
Recoflavone - 203191-10-0 -
Revaprazan - 199463-33-7 -
R-Pantoprazol Magnesium - 657391-79-2 -
S S - Pantoprazole Sodium - 1416988-58-3 -
Sennoside A - 81-27-6 -
Sennoside B - 128-57-4 -
Silymarin (Milk thistle P.E) - 65666-07-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 92 API Gastrointestinal
Product Pharmacopoeia CAS No. Technical Document
Simethicone Emulsion USP 9016-00-6 -
Sodium Dehydrocholate - 145-41-5 -
Sodium Gualenate BP, EP, USP 6223-35-4 GMP
Sofalcone - 64506-49-6
T Teduglutide - 197922-42-2 GMP, WHO-GMP
Telotristat Etiprate - 1137608-69-5 -
Timonium Methyl Sulfate - 6504-57-0 Tech Pack
Tinidazole - 19387-91-8 -
Trimebutine Base - 39133-31-8 -
Trimebutine Maleate EP 7.5, KP 34140-59-5 -
U Ursodeoxycholic Acid BP, EP, USP 128-13-2 DMF, GMP, Tech Pack
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 93 API HIV-AIDS
Product Pharmacopoeia CAS No. Technical Document
A Abacavir - 136470-78-5 - - Abacavir Sulfate 188062-50-2 - - B Bictegravir 1611493-60-7 - - Bictegravir Sodium 1807988-02-8 - - Bifendate 73536-69-3 - - C Cenicriviroc Mesylate 497223-28-6 - - Cobicistat 1004316-88-4 -
D Didanosine - 69655-05-6 -
Dolutegravir - 1051375-16-6 -
Dolutegravir Sodium - 1051375-19-9 Tech Pack
E Efavirenz - 154589-52-4 -
Efavuirenz - 73590-52-4 -
Elvitegravir - 697761-98-1 -
Entecavir Monohydrate - 209216-23-9 ISO 9001:2015 1H NMR, CoA, HPLC, Etravirine - 269055-15-4 Mass, IR F Fostemsavir - 864953-29-7 -
I Indinavir - 150378-17-9 -
Indinavir Sulphate - 157810-81-6 cGMP, GMP
L Lamivudine - 134678-17-4 -
Ledipasvir - 1256388-51-8 -
Ledipasvir (Acetone) - 1441674-54-9 -
Lopinavir - 192725-17-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 94 API HIV-AIDS
Product Pharmacopoeia CAS No. Technical Document
N Nelfinavir - 188936-07-4 -
R Raltegravir - 518048-05-0 - Sample, Tech Pack, Raltegravir Potassium - 871038-72-1 USDMF Rilpivirine - 500287-72-9 -
S Saquinavir - 127779-20-8 -
T Tenofovir Alafenamide - 379270-37-8 - Tenofovir Alafenamide - 1392275-56-7 GMP Fumarate Tenofovir Disoproxil - 201341-05-1 - Tenofovir Disoproxil - 1571075-19-8 - Aspartate Tenofovir Disoproxil - 202138-50-9 - Fumarate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 95 API Hormones
Product Pharmacopoeia CAS No. Technical Document
A Abarelix - 183552-38-7 -
Adrenocorticotropic Hormone - 16960-16-0 -
Alarelin - 79561-22-1 - DMF, ISO14001:2004, Allylestrenol BP, EP, IP, USP 432-60-0 ISO9001:2008, Tech Pack, USFDA Antide Acetate - 112568-12-4 -
Atosiban - 90779-69-4 -
C Calcitonin - 9007-12-9 -
Carbimazole - 22232-54-8 DMF
Carbetocin - 37025-55-1 -
Cetrorelix - 120287-85-6 -
Cinacalcet Hydrochloride - 364782-34-3 US-FDA
Clomifene - 911-45-5 -
Clomifene Citrate - 50-41-9 -
Clomiphene Citrate BP, IP, USP 88431-47-4 -
Clomiphene Citrate USP32 43054-45-1 -
Cloprostenol Sodium - 55028-72-3 GMP
Cyproterone Acetate - 427-51-0 -
D Danazol - 17230-88-5 - Dehydroepiandrosterone - 853-23-6 - Acetate Deslorelin - 57773-65-6 -
Desmopressin - 16679-58-6 -
Desmopressin Acetate - 16789-98-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 96 API Hormones
Product Pharmacopoeia CAS No. Technical Document ISO14001:2004, Desogestrel - 54024-22-5 ISO9001:2008, Tech Pack, USFDA Diethylstilbestrol - 56-53-1 GMP, WHO-GMP
Drospirenone - 67392-87-4 - ISO14001:2004, Dydrogesterone - 152-62-5 ISO9001:2008, Tech Pack, USFDA E Elagolix IHS 834153-87-6 TP
Elagolix Sodium - 832720-36-2 -
Esterified Estrogen - 7280-37-7 - DMF, ISO14001:2004, 35380-71-3, Estradiol & Derivatives - ISO9001:2008, Tech Pack, 50-28-2 USFDA Estradiol Benzoate - 50-50-0 -
Estradiol Cypionate - 313-06-4 -
Estradiol Enanthate - 4956-37-0 - DMF, ISO14001:2004, Estradiol Hemihydrate - 35380-71-3 ISO9001:2008, Tech Pack, USFDA DMF, ISO14001:2004, Estradiol Valerate - 979-32-8 ISO9001:2008, Tech Pack, USFDA Etelcalcetide - 1262780-97-1 - DMF, ISO14001:2004, Ethinyl Estradiol BP, EP, IP, USP 57-63-6 ISO9001:2008, Tech Pack, USFDA Ethisterone - 434-03-7 -
G Ganirelix - 123246-29-7 -
Ganirelix Acetate - 129311-55-3 GMP, WHO GMP
Gestonorone IHS 2137-18-0 -
Gestonorone Acetate - 31981-44-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 97 API Hormones
Product Pharmacopoeia CAS No. Technical Document
Gestrinone - 16320-04-0 - 33515-09-2, Gonadorelin - - 71447-49-9 Goserelin - 65807-02-5 -
H Histrelin - 76712-82-8 -
Histrelin Acetate IHS 220810-26-4 -
Hydroxyprogesterone - 68-96-2 -
Hydroxyprogesterone Caproate IP, USP 630-56-8 DMF DMF, ISO14001:2004, L Levonorgestrel BP, EP, IP, USP 797-63-7 ISO9001:2008, Tech Pack, USFDA 1H NMR, CoA, HPLC, Mass, Levothyroxine Sodium - 55-03-8 IR Levothyroxine Sodium Hydrate BP, JP, USP 25416-65-3 DMF
Liothyronine - 6893-02-3 USDMF
L-Thyroxine - 51-48-9 - DMF, ISO14001:2004, Lynestrenol - 52-76-6 ISO9001:2008, Tech Pack, US-FDA Lypressin - 50-57-7 -
M Medrogestone - 977-79-7 - ISO14001:2004, Medroxyprogesterone Acetate - 71-58-9 ISO9001:2008, Tech Pack, US-FDA Megestrol Acetate - 595-33-5 -
Melatonine USP 73-31-4 GMP, WHO GMP
Melengestrol Acetate - 2919-66-6 -
Mesterolone BP, EP 1424-00-6 -
Methimazole - 60-56-0 DMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 98 API Hormones
Product Pharmacopoeia CAS No. Technical Document
Methyltestosterone - 58-18-4 -
N Norethisterone - 68-22-4 -
Norethisterone Acetate - 51-98-9 - 79517-01-4, Octreotide - - O 83150-76-9 Octreotide Acetate - 83150-76-9 - ISO14001:2004, Ospemifene - 128607-22-7 ISO9001:2008, Tech Pack, USFDA Oxymetholone - 434-07-1 -
Oxytocin - 50-56-6 -
P Paricalcitol - 131918-61-1 -
Pasireotide - 396091-73-9 GMP, WHO GMP
Progesterone - 57-83-0 -
Propylthiouracil - 51-52-5 DMF
Protirelin - 24305-27-9 -
pTH(1-34) (Human) - 52232-67-4 -
S Sermorelin - 86168-78-7 -
Somatostatin - 51110-01-1 -
Somatropin - 12629-01-5 -
T Taltirelin - 103300-74-9 -
Terlipressin - 14636-12-5 -
Tesamorelin - 804475-66-9 -
Testosterone - 58-22-0 -
Testosterone Decanoate - 5721-91-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 99 API Hormones
Product Pharmacopoeia CAS No. Technical Document DMF, ISO14001:2004, Testosterone Enanthate BP, EP, IP, USP 315-37-7 ISO9001:2008, Tech Pack, USFDA Testosterone Pnenylpropionate - 1255-49-8 -
Testosterone Undecanoate - 5949-44-0 -
Thyroid Powder - 50809-32-0 -
Tiratricol - 51-24-1 -
Triptorelin Acetate - 57773-63-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 100 API Immunosuppressants
Product Pharmacopoeia CAS No. Technical Document
A Azathioprine BP, EP, USP 446-86-6 cGMP, DMF, CEP, WC
B Baricitinib - 1187594-09-7 -
Baricitinib Phosphate Salt - 1187595-84-1 -
Bergenin BP, EP, USP 477-90-7 GMP
C Cyclosporin A - 59865-13-3 -
D Dimethyl Fumarate - 624-49-7 -
E Everolimus - -
F Fingolimod - 162359-55-9 -
Fingolimod Hydrochloride - 162359-56-0 -
I Infliximab IHS 170277-31-3 -
L Lentinan - 37339-90-5 -
M Mizoribine - 50924-49-7 - 115007-34-6, Mycophenolate Mofetil BP, EP, IP, USP DMF 128794-94-5 Mycophenolate Sodium - 37415-62-6 DMF 1H NMR, CoA, HPLC, Mycophenolic Acid - 24280-93-1 Mass, IR N-Acetyl-D-Glucosamine - 7512-17-6 - N (Vegan) Nitisinone - 104206-65-7 -
O Obeticholic Acid - 459789-99-2 -
P Pimecrolimus - 137071-32-0 -
S Sirolimus (Rapamycin) - 53123-88-9 -
T Tacrolimus - 104987-11-3 -
Tacrolimus Monohydrate - 109581-93-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 101 API Immunosuppressants
Product Pharmacopoeia CAS No. Technical Document
Teriflunomide - 163451-81-8 EDMF
Thalidomide USP 50-35-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 102 API Laxatives
Product Pharmacopoeia CAS No. Technical Document
B Bisacodyl BP, EP, USP 603-50-9 DMF, WC
C Castor Oil FSG, PP 8001-79-4 -
D Docusate Sodium EP, USP 577-11-7 DMF, WC
O Oxyphenisatin Acetate - 115-33-3 -
Sodium Phosphate - 7558-80-7 - S Monobasic Anhydrous Sodium Picosulfate BP, EP, JP 10040-45-6 DMF, WC Sodium Picosulfate JP 1307301-38-7 - hydrate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 103 API Mineral Supplements
Product Pharmacopoeia CAS No. Technical Document
M Maganese Citrate - 10024-66-5 - Magnesium Acetate - 16674-78-5 - Tetrahydrate Magnesium Ascorbyl - 113170-55-1 - Phosphate Magnesium Aspartate BP, FCC, IP, NF, USP 18962-61-3 -
Magnesium Bicarbonate - 2090-64-4 - Magnesium Bromide - 29858-07-9 - Diethyl Etherate Magnesium Carbonate - 546-93-0 - Heavy / Light Magnesium Chloride - 7786-30-3 - Anhydrous Magnesium Citrate - 7779-25-1 - Magnesium Citrate - 3344-18-1 - Dodecahydrate Magnesium Citrate Malate BP, FCC, IP, NF, USP 1259381-40-2 CGMP, FSSC, ISO
Magnesium Fumarate BP, FCC, IP, NF, USP 7704-71-4 -
Magnesium Gluconate BP, FCC, IP, NF, USP 3632-91-5 CGMP, FSSC, ISO
Magnesium Hydroxide - 1309-42-8 - Magnesium - 10377-57-8 - HypoPhosphite Magnesium Lactate BP, FCC, IP, NF, USP 18917-93-6 -
Magnesium Malate - 869-06-7 -
Magnesium Methionate - 106207-65-2 -
Magnesium Orotate BP, FCC, IP, NF, USP 27067-77-2 -
Magnesium Peroxide BP, FCC, IP, NF, USP 1335-26-8 CGMP, FSSC, ISO Magnesium Phosphate - 7757-87-1 - Anhydrous Magnesium Silicate - 1343-88-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 104 API Mineral Supplements
Product Pharmacopoeia CAS No. Technical Document
Magnesium Sulfate - 7487-88-9 - Anhydrous Magnesium Sulphate - 14168-73-1 - Monohydrate Magnesium Trisilicate - 14987-04-3 - Magnesium Turning /Metal - 7439-95-4 - Powder Magnesium-P- - 14926-08-0 - Aminobenzoate Manganese Bisglycinate - 14281-77-7 - Manganese Chloride - 7773-01-5 - Anhydrous Manganese Chloride - 13446-34-9 - Tetrahydrate Manganese Gluconate USP 6485-39-8 -
Manganese Lactate BP, FCC, IP, NF, USP 51877-53-3 -
P Potassium Chloride - 7447-40-7 -
Potassium Citrate BP, EP, IP, USP 866-84-2 -
Potassium Citrate Dibasic - 3609-96-9 -
Potassium Iodate (KIO3) - 7758-05-6 -
Potassium Orotate BP, FCC, IP, NF, USP 24598-73-0 - Potassium Phosphate - 7758-11-4 - Dibasic Potassium Pyrophosphate - 7320-35-5 - Potassium Sodium - 304-59-6 - Tartrate Potassium Sodium L-(+)- - 6381-59-5 - Tartrate S Sodium Chloride - 7647-14-5 -
Sodium Selenite BP 10102-18-8 - Sodium Selenite - 26970-82-1 - Pentahydrate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 105 API Mineral Supplements
Product Pharmacopoeia CAS No. Technical Document
Z Zinc Acetate - 5970-45-6 -
Zinc Aspartate - 36393-20-1 -
Zinc Gluconate USP 4468-02-4 - cGMP, FSSC22000, Zinc Lysinate BP, FCC, IP, NF, USP 7214-08-6 Halal, Kosher Zinc Malate - 2847-05-4 -
Zinc Sulphate Heptahydrate - 7446-20-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 106 API Muscle Relaxants
Product Pharmacopoeia CAS No. Technical Document
A Atracurium Besylate BP, USP 64228-81-5 -
B Baclofen - 1134-47-0 -
C Carisoprodol BP, EP, USP 78-44-4 DMF, Tech Pack
Chlorzoxazone USP 95-25-0 --
Cisatracurium Besylate - 96946-42-8 -
Colchicoside - 477-29-2 EDQM, USFDA, WHO Geneva DMF, EU-GMP, FDA, FSSAI, 477-29-2, Colchicoside & Thiocolchicoside - FSSC, GMP, HALAL, ISO, 602-41-5 KOSHER, WHO-GMP Cyclobenzaprine Hydrochloride - 6202-23-9 DMF
D Dantrolene Sodium - 24868-20-0 -
Dantrolene Sodium Salt - 14663-23-1 -
E Eperisone Hydrochloride JP 56839-43-1 Tech Pack
I Idrocilamide IHS 6961-46-2 -
M Mephenesin BP 59-47-2 WC
Methocarbamol USP 532-03-6 DMF, CEP
O Orphenadrine Citrate - 4596-23-0 -
Orphenadrine Hydrochloride BP, EP 341-69-5 -
P Pancuronium Bromide Impurities EP 15500-66-0 -
Phenerymidol - 553-69-5 - AFSSAPS ( France), ANVISA ( Brazil), BfArM (Germany), Cofepris ( Mexico), EDQM, Phenprobamate - 673-31-4 ISMS, ISO 9001:2000, OHSAS, PMDA (Japan), TGA (Australia), US FDA Phenyramidol Hydrochloride - 326-43-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 107 API Muscle Relaxants
Product Pharmacopoeia CAS No. Technical Document
Prilocaine Base - 721-50-6 -
Prilocaine Hydrochloride - 1786-81-8 -
Procaine Hydrochloride BP, EP, JP 51-05-8 -
R Rocuronium Bromide EP 119302-91-9 -
S Succinylcholine Chloride - 71-27-2 -
Succinylcholine Chloride - 6101-15-1 -
T Tetrahydropalmatine - 10097-84-4 -
Tizanidine Hydrochloride - 64461-82-1 -
Tetrahydropalmatine JP 3644-61-9 Tech Pack
V Valethamate Bromide - 90-22-2 -
Vecuronium EP 50700-72-6 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 108 API Musculoskeletal
Product Pharmacopoeia CAS No. Technical Document
A Acemetacin - 53164-05-9 -
Agmatine Sulfate - 2482-00-0 - Aspartyl-alanyl- - 397847-46-0 - diketopiperazine ,98%NLT Ataluren PTC-124 - 775304-57-9 -
D Diacerein BP, EP, IP 13739-02-1 DMF
Diethylamine Salicylate - 4419-92-5 -
F Filgotinib - 1206161-97-8 -
G Glucosamine - 3416-24-8 -
Glucosamine Sulfate USP 14999-43-0 - Glucosamine Sulphate - 1296149-08-0 - Potassium Glucosamine Sulphate - 38899-05-7 - Potassium Chloride L Leflunomide - 75706-12-6 SFDA
P Pelubiprofen - 69956-77-0 -
U Upadacitinib - 1310726-60-3 Tech Pack
Upadacitinib Tartrate - 1607431-21-9 -
V Valecoxib - 181695-72-7 - 165800-06-6, Zoledronic Acid - DMF, WC Z 118072-93-8 Zucapsaicin - 25775-90-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 109 API Obesity Management
Product Pharmacopoeia CAS No. Technical Document
C Cetilistat - 282526-98-1 -
L Lorcaserin Hydrochloride - 846589-98-8 -
O Orlistat USP 96829-58-2 CGMP
P Phentermine Hydrochloride USP 1197-21-3 -
R Rimonabant - 168273-06-1 -
Sibutramine Immediate Release - 106650-56-0 - S Pellets 5% w/w AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, ISO22000, ISO9001, NSF-cGMP, OU- Synephrine - 94-07-5 Kosher, QC , SFDA-GMP, USFDA
Synephrine Tartrate - 16589-24-5 -
- -
Z Zilpaterol Hydrochloride - 119520-06-8 Tech Pack
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 110 API Opthalmologicals
Product Pharmacopoeia CAS No. Technical Document
A Acetazolamide BP, EP, USP, JP 59-66-5 WC
Alcaftadine IHS 147084-10-4 -
Apraclonidine Hydrochloride - 73218-79-8 -
Atropine USP 51-55-8 GMP, WHO-GMP
Atropine Sulfate - 5908-99-6 -
Atropine Sulphate - 55-48-1 -
Azelastine - 58581-89-8 -
B Bimatoprost BP, EP, USP 155206-00-1 GMP
Brimonidine - 59803-98-4 -
Brimonidine Tartrate IHS 59803-94-4 GMP, USDMF
Brinzolamide USP 138890-62-7 WC
C Carboprost Tromethamine - 58551-69-2 Tech Pack
Cyclopentolate - 512-15-2 -
Cyclopentolate Hydrochloride - 5870-29-1 -
D Diquafosol Tetrasodium - 59985-21-6 -
Dorzolamide - 120279-96-1 - 130693-82-2, Dorzolamide Hydrochloride - DMF 30693-82-2 F Fluorescein Sodium - 518-47-8 EP, USP
H Homatropine Hydrobromide - 51-56-9 -
Homatropine Methylbromide - 80-49-9 - 9001-54-1, Hyaluronidase BP, EP, USP GMP 37326-33-3
L Latanoprost - 130209-82-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 111 API Opthalmologicals
Product Pharmacopoeia CAS No. Technical Document
Levocabastine Hydrochloride EP, USP 79547-78-7 DMF
Lifitegrast - 1025967-78-5 -
Loteprednol Etabonate - 82034-46-6 DMF
M Methazolamide - 554-57-4 -
N N-Acetyl Carnosine - 56353-15-2 GMP
Naphazoline Hydrochloride JP, EP, USP 550-99-2 -
Naphazoline Nitrate BP, EP 5144-52-5 DMF
Nepafenac - 78281-72-8 DMF, WC
Netarsudil - 1254032-66-0 -
O Olopatadine - 113806-05-6 - Olopatadine Hydrochloride - 55453-87-76 DMF, USDMF Intermediate(Isozepac) Olopatadine Hydrochloride - 140462-76-6 -
P Physostigmine - 57-47-6 -
Prednisolone Acetate - 52-21-1 -
Proparacaine Hydrochloride - 5875-06-9 -
T Tafluprost - 209860-87-7 Tech Pack
Travoprost - 157283-68-6 -
Trehalose Dihydrate - 6138-23-4 -
Trifluridine - 70-00-8 -
Tropicamide BP, IP, USP, EP 1508-75-4 Tech Pack, WC
V Verteporfin - 129497-78-5 -
X Xylometazoline Hydrochloride - 1218-35-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 112 API Osteoporosis
Product Pharmacopoeia CAS No. Technical Document
A Abaloparatide - 247062-33-5 -
Alendronate Sodium - 121268-17-5 - Alendronate Sodium - 12168-17-5 - Trihydrate Alphacalcidol - 41294-56-8 -
B Bazedoxifene - 198481-32-2 -
Bazedoxifene Acetate - 198481-33-3 -
C Clodronic Acid - 10596-23-3 - Clodronic Acid N- - 163706-61-4 - Butylamine Salt Disodium Clodronate - 88416-50-6 - D Tetrahydrate Disodium Pamidronate - 109552-15-0 GMP, WHO GMP
E Elcatonin - 60731-46-6 -
Eldecalcitol - 104121-92-8 -
Etidronate Disodium BP, EP, USP 7414-83-7 -
G Glucosamine Hydrochloride USP 66-84-2 -
I Ibandronate Sodium - 138844-81-2 -
Ipriflavone - 35212-22-7 -
L Lasofoxifene Tartrate - 190791-29-8 -
M Magnolol - 528-43-8 -
P Pamidronate Disodium BP 57248-88-1 -
Pamidronic Acid - 40391-99-9 WHO GMP
R Raloxifene - 84449-90-1 -
Raloxifene Hydrochloride BP, USP 82640-04-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 113 API Osteoporosis
Product Pharmacopoeia CAS No. Technical Document
Risedronate Sodium USP 115436-72-1 WC Risedronate Sodium - 329003-65-8 - Hemipentahydrate Risedronic Acid - 105462-24-6 - cGMP, FSSC22000, Strontium Lactate - 29870-99-3 S Halal, Kosher Strontium Ranelate - 135459-87-9 EDMF
T Teriparatide - 52232-67-4 -
Trimegestone IHS 74513-62-5 -
Z Zoledronate - 118072-93-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 114 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
A Acebrophylline - 179118-73-1 DMF, WC
Aceclofenac BP, EP 89796-99-6 DMF, CEP
Ademetionine - 17176-17-9 -
Ademetionine Disulfate Tosylate - 97540-22-2 -
Alminoprofen - 39718-89-3 -
Almotriptan - 154323-57-6 WC
Almotriptan Malate - 181183-52-8 ASMF, CEP, USDMF
Amfenac Sodium - 61618-27-7 -
Aminophenazone - 58-15-1 -
Amtolmetin Guacil - 87344-06-7 - 5907-38-0, Analgin - - 68-89-3 Aspirin (Acetylsalicylic acid) - 50-78-2 -
B Benorilate - 5003-48-5 -
Benzydamine Hydrochloride BP 132-69-4 DMF, WC AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Boldine - 476-70-0 ISO22000, ISO9001, NSF-cGMP, OU-Kosher, QC , SFDA-GMP, USFDA Bromfenac Sodium - 120638-55-3 -
Bumadizone Calcium - 34461-73-9 -
Buprenorphine EP, USP 52485-79-7 -
Buprenorphine Hydrochloride BP, EP, USP 53152-21-9 -
Betamethasone Sodium Phosphate BP, USP 151-73-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 115 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
Betamethasone Valerate BP, EP, USP 5593-20-4 DMF, WC
C Carbasalate Calcium - 5749-67-7 -
Carperitide Acetate - 89213-87-6 -
Cebranopadol Hemicitrate - 863513-92-2 -
Celecoxib BP, EP, USP 169590-42-5 DMF, CEP, WC
Choline Salicylate - 2016-36-6 -
Chymotrypsin - 9004-07-3 -
Cilostazol USP 73963-72-1 Tech Pack
Clobetasol Propionate BP, USP 25122-46-7 DMF, WC
D Darbufelone - 139226-28-1 -
Dexibuprofen - 51146-56-6 -
Dexketoprofen - 22161-81-5 -
Dexketoprofen Trometamo - 156604-79-4 Tech Pack
Diclofenac Diethylamine - 78213-16-8 -
Diclofenac Potassium - 15307-81-0 - EDQM, USFDA, Who Diclofenac Sodium BP, EP, USP 15307-79-6 Geneva, DMF, CEP, WC, GMP Diflunisal - 22494-42-4 USDMF
D-Penicillamine - 52-67-5 -
E Eletriptan Hydrobromide - 177834-92-3 Tech Pack Eletriptan Hydrobromide EP, USP 273211-28-2 ASMF, CEP, USDMF Monohydrate Etodolac - 41340-25-4 -
Etoricoxib - 202409-33-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 116 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
F Felbinac - 5728-52-9 -
Fentanyl Base EP 437-38-7 -
Fentanyl Citrate EP, USP 990-73-8 DMF
Flunixin Meglumine - 42461-84-7 DMF
Flupirtine - 56995-20-1 -
Flupirtine Maleate - 75507-68-5 -
Fluproquazone - 40507-23-1 -
Flurbiprofen - 5104-49-4 -
Flurbiprofen Axetil - 91503-79-6 -
Flurbiprofen Sodium - 56767-76-1 -
H Hydromorphone Hydrichloride USP 71-68-1 - 1H NMR, CoA, HPLC, Ibuprofen - 15687-27-1 I Mass, IR Ibuprofen Lysinate - 57469-76-8 EDMF
Ibuprofen Piconol - 64622-45-3 -
Iguratimod - 123663-49-0 -
Indometacin USP 53-86-1 -
Indomethacin Sodium - 7681-54-1 -
K Ketoprofen - 22071-15-4 CGMP
Ketoprofen Lysine - 7469-78-0
Ketorolac Tromethamine EP, USP 74103-07-4 WC
L Levomethadone Hydrochloride - 5967-73-7 -
Licofelone - 156897-06-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 117 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
Lornoxicam - 70374-39-9 -
Losmiprofen - 74168-08-4 -
Loxoprofen - 68767-14-6 -
Loxoprofen Sodium JP 80382-23-6 Tech Pack
M Mefenamic Acid BP, IP 61-68-7 -
Meloxicam BP, EP, USP 71125-38-7 DMF, WC
Mepivacaine Hydrochloride - 1722-62-9 -
Meptazinol Hydrochloride - 59263-76-2 -
Mesalamine - 89-57-6 -
Metamizole Sodium - 68-89-3 -
Methadone Hydrochloride EP, USP 1095-90-5 DMF
Mirogabalin - 1138245-13-2 -
Morphine Sulfate USP 64-31-3 -
Myrtecaine - 7712-50-7 -
N Nabumetone BP, EP, JP, USP 42924-53-8 WC
Nalbuphine Hydrochloride - 23277-43-2 DMF
Naproxen BP, EP, IP, JP, USP 22204-53-1 WC
Naproxen Sodium EP, USP 26159-34-2 WC AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Naringin - 10236-47-2 ISO22000, ISO9001, NSF-cGMP, OU-Kosher, QC , SFDA-GMP, USFDA
Nepafenac - 78281-72-8 DMF, WC
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 118 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
Nefopam - 13669-70-0 Tech Pack EDQM, USFDA, Who Nimesulide - 51803-78-2 Geneva Nimodipine - 66085-59-4 -
O Oliceridine - 1401028-24-7 ISO
Oxaceprol - 33996-33-7
Oxycodone Hydrochloride BP 124-90-3 -
P Paeonol - 552-41-0 -
Paracetamol / Acetaminophen BP, USP 103-90-2 DMF, WC
Parthenolide - 20554-84-1 - Pethidine Hydrochloride BP, EP, USP 50-13-5 EDMF (Mepiridine Hydrochloride) Penicillamine - 52-67-5 DMF
Phenacetin BP 62-44-2 GMP
Phenylbutazone - 50-33-9 -
Phenylbutazone Calcium - 70145-60-7 -
Piritramide - 302-41-0 -
Piroxicam BP, EP, USP 36322-90-4 DMF
Piroxicam-β-cyclodextrin - 96684-39-8
Pitofenone Hydrochloride - 1248-42-6 EDMF, WC
Polmacoxib - 301692-76-2 -
Pramoxine Hydrochloride USP 637-58-1 Tech Pack
Pranoprofen - 52549-17-4 -
Propacetamol Hydrochloride EP 66532-86-3 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 119 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
Propyphenazone/Isopropylantipyrine IP, JP, EP 479-92-5 - R-(-)-2-Fluoro-alpha-methyl-4- - 51543-40-9 - R biphenylacetic acid (Flurbiprofen) Ralfinamide - 133865-88-0 -
Remifentanil Hydrochloride EP 132539-07-2 -
Ropivacaine - 84057-95-4 -
Ropivacaine Hydrochloride - 132112-35-7 -
Ropivacaine Mesylate - 854056-07-8 -
Rosiptor - 782487-28-9 - AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Ruscogenin - 472-11-7 ISO22000, ISO9001, NSF-cGMP, OU-Kosher, QC , SFDA-GMP, USFDA Rutaecarpine - 84-26-4 -
S Salsalate - 552-94-3 - Sodium Butazolidine BP 129-18-0 WHO-GMP (Phenylbutazone Sodium) Sodium Salicylate - 54-21-7 -
Sodium Tolmetin Dihydrate - 64490-92-2 -
Sulindac - 38194-50-2 GMP
T Tapentadol - 175591-23-8 -
Tapentadol Hydrochloride - 175591-09-0 -
Tenoxicam - 59804-37-4 -
Tiaprofenic Acid EP 33005-95-7 WC
Tolfenamic Acid - 13710-19-5 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 120 API Pain Management
Product Pharmacopoeia CAS No. Technical Document
Tramadol BP, EP, USP 27203-92-5 CEP, WC
Tramadol Hydrochloride BP, EP 22204-88-2 -
Tramadol Hydrochloride - 73806-49-2 -
Triamcinolone Acetonide BP, EP, USP 76-25-5 WC
Trypsin - 9002-07-7 -
Z Ziconotide - 107452-89-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 121 API Rare Drugs
Product Pharmacopoeia CAS No. Technical Document
C Carglumic Acid - 1188-38-1 DMF
D Dinaciclib - 779353-01-4 -
F Fomepizole - 7554-65-6 DMF
M Migalastat - 108147-54-2 -
Miglustat - 72599-27-0 -
T Trientine Hydrochloride USP 38260-01-4 DMF
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 122 API Steroidals
Product Pharmacopoeia CAS No. Technical Document
Beclomethasone - 4419-39-0 GMP B Dipropionate Betamethasone - 378-44-9 - Betamethasone 21- - - Phosphate Disodium Betamethasone Acetate - 987-24-6 - Betamethasone BP, USP 5593-20-4 - Dipropionate Betamethasone Sodium - 151-73-5 - Phosphate Betamethasone Valerate BP, USP 2152-44-5 -
Budesonide BP, EP 51333-22-3 WC
C Canrenoic Acid - 4138-96-9 DMF
Clobetasol Propionate BP, EP, USP 25122-46-7 DMF 25122-57-0, Clobetasole Butyrate BP, USP - 54063-32-0 Clobetasole Propionate BP, USP 25122-41-2 -
Clobetasone Butyrate - 21522-57-0 -
Cloprednol - 5251-34-3 -
D Deflazacort - 14484-47-0 - Dexamethasone 21- 2392-39-4, - - phosphate Disodium Salt 55203-24-2 Dexamethasone Sodio - 55203-24-2 GMP, WHO GMP Phosphate Dexamethasone - 1950-2-2
Difluprednate - 23674-86-4 USDMF
Dihydrotachysterol-2 - 67-96-9 WC
Dexamethasone Acetate - 1177-87-3 - DMF, ISO14001:2004, E Ethylestrenol BP, EP, IP, USP 965-90-2 ISO9001:2008, Tech Pack, US-FDA
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 123 API Steroidals
Product Pharmacopoeia CAS No. Technical Document
AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Euphobiasteroid - 28649-59-4 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA EU-GMP, US-FDA, Flumethasone Pivalate - 2002-29-1 F WHO GMP Fluocinonide - 356-12-7 -
Fluocortolone - 152-97-6 GMP
Fluorometholone USP32 426-13-1 -
Fluorometholone Acetate - 3801-06-7 -
Fluticasone - 90566-53-3 -
Fluticasone Furoate BP, EP, IP 397864-44-7 USFDA
Fluticasone Propionate BP, EP, IP 80474-14-2 EDMF, USFDA
G Galeterone - 851983-85-2 -
H Halcinonide -- 3093-35-4 -
Halobetasol Propionate USP 66852-54-8 USDMF Halometasone 50629-82-8 - Monohydrate Hydrocortisone EP 50-23-7 -
Hydrocortisone Acetate - 50-03-3 -
Hydrocortisone Butyrate - 13609-67-1 - ISO14001:2004, Hydrocortisone Hemi 83784-20-7, ISO9001:2008, Tech Pack, - Succinate 2203-97-6 US-FDA, EU-GMP, US- FDA, WHO GMP Hydrocortisone Sodium EU-GMP, US-FDA, Succinate (buffered sterile - 125-04-2 WHO GMP lyophilized) Hydrocortisone Valerate - 57524-89-7 GMP Mehtyprednisolone - 2921-57-5 - M Hemisuccinate
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 124 API Steroidals
Product Pharmacopoeia CAS No. Technical Document
Methyl Prednisolone - 53-36-1 - Acetate Methylprednisolone BP, EP, USP 83-43-2 - Methylprednisolone - 86401-95-8 - Aceponate Methylprednisolone - 56-36-1 - Acetate Methylprednisolone - 2375-03-3 - Sodium Succinate Mometasone - 105102-22-5 -
Mometasone Furoate BP, EP, USP 83919-23-7 DMF Mometasone Furoate - 141646-00-6 - Monohydrate DMF, ISO14001:2004, N Nandrolone Undecanoate BP, EP, IP, USP 862-89-5 ISO9001:2008, Tech Pack, US-FDA Prednisolone EU-GMP, US-FDA, - 2920-86-7 P Hemisuccinate WHO GMP ISO14001:2004, Prednisolone Sodium - 125-02-0 ISO9001:2008, Tech Pack, Phosphate US-FDA Prednisolone Sodium 125-02-0, BP, EP, USP WC Phosphate 8056-11-9 Prednisone - 53-03-2 -
Pregnenolone Acetate - 1778-02-5 - AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Protodioscin - 55056-80-9 ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA Prednisolone BP, USP 50-24-8 -
Prednisolone Acetate BP, USP 52-21-1 WC
S Stanozolol - 10418-03-8 -
T Tetracosactide - 22633-88-1 -
Trenbolone Enanthate USP 1629618-98-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 125 API Steroidals
Product Pharmacopoeia CAS No. Technical Document
Triamcinolone Acetonide - 76-25-5 - Triamcinolone Acetonide - 3870-07-3 - Acetate Triamcinolone Diacetate - 67-78-7 - Triamcinolone - 5611-51-8 - Hexacetonide Triamcinolone BP, EP, USP 124-94-7 WC
Testosterone Propionate - 57-85-2 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 126 API Thrombosis Management
Product Pharmacopoeia CAS No. Technical Document
A Acenocoumarol BP 152-72-7 -
Apixaban - 503612-47-3 -
Aprotinin - 9087-70-1 -
Argatroban Monohydrate - 141396-28-3 -
Avatrombopag Maleate - 677007-74-8 --
B Betrixaban - 330942-05-7
Betrixaban Hydrochloride - 2099719-47-6 -
Betrixaban Maleate - 936539-80-9 -
Bivalirudin - 128270-60-0 -
C Carbazochrome JP 69-81-8 DMF Carbazochrome Sodium - 51460-26-5 GMP Sulfonate Clocoumarol - 35838-63-2 -
Clopidogrel - 113665-84-2 -
Clopidogrel Besylate - 7744256-69-0 -
Clopidogrel Bisulphate - 120202-66-6 -
Clopidogrel Hydrochloride - 90055-48-4 WC Clopidogrel Hydrogen - 135046-48-9 GMP sulfate 211915-06-9, Dabigatran - - D 211914-51-1 Dabigatran Elexilate 593282-20-3, - - Mesylate 872728-81-9 Dabigatran Etexilate IHS 211915-06-9 -
Dabigatran Hydrochloride - 1019206-66-6 -
Dextran - 9004-54-0 GMP
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 127 API Thrombosis Management
Product Pharmacopoeia CAS No. Technical Document
Dipyridamole - 58-32-2 -
E Edoxaban - 480449-70-5 - Edoxaban (Hydrochloride - 480448-29-1 - Salt) Edoxaban Isomer - 1255529-24-8 - 480449-71-6, Edoxaban Tosylate - - 912273-65-5 Edoxaban Tosylate - 1229194-11-9 - Monohydrate Eltrombopag Acid - 496775-61-2 -
Eltrombopag Olamine - 496775-62-3 -
Enoxaparin Sodium - 679809-58-6 -
Eptifibatide - 188627-80-7 -
Eribaxaban - 536748-46-6 -
Etamsylate BP, EP 2624-44-4 -
F Fondaparinux Sodium - 114870-03-0 -
Fostamatinib - 901119-35-5 -
H Heparin Sodium USP 9041-08-1 GMP, WHO GMP
I Indobufen - 63610-08-2 -
N Nafamostat Mesylate - 82956-11-4 -
P Pentoxifylline BP, EP 6493-05-6 WC
Phenprocoumon - 435-97-2 WC Sample, Tech Pack, Prasugrel Hydrochloride - 389574-19-0 USDMF PRT-060318 - 1194961-19-7 -
R Rivaroxaban - 366789-02-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 128 API Thrombosis Management
Product Pharmacopoeia CAS No. Technical Document
S Setipafant - 132418-35-0 -
T Ticagrelor - 274693-27-5 -
Ticlopidine BP, EP, USP 55142-85-3 -
Tirofiban Hydrochloride - 150915-40-5 -
Tranexamic Acid - 701-54-2 -
Treprostinil - 81846-19-7 -
W Warfarin Sodium Clathrate - 67430-45-9 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 129 API Tuberculosis Management
Product Pharmacopoeia CAS No. Technical Document
B Bedaquiline Free Base - 843663-66-1 -
Bedaquiline Fumarate - 845533-86-0 -
Benzofuroxan - 480-96-9 -
Berberine Hydrochloride - 633-65-8 -
E Elthambutol Hydrochloride BP, IP, USP 107-11-7 - 1070-11-7, Ethambutol - - 74-55-5 Ethambutol Hydrochloride BP 2010 1070-11-7 GMP
Ethionamide BP 536-33-4 - N-(4-bromophenyl)-3- - 316146-27-7 - N phenylpropanamide P Para Amino Salicylic Acid - 65-49-6 - Para Amino Sodium - 6018-19-5 - Salicylate Prothionamide BP 14222-60-7 -
Pyrazinamide BP, EP, USP 98-96-4 WC
P Terizidone - 25683-71-0 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 130 API Urology
Product Pharmacopoeia CAS No. Technical Document
A Alfuzosin - 81403-80-7 -
Alfuzosin Hydrochloride EP 81403-68-1 GMP
B Bethanechol Chloride - 590-63-6 -
D Darifenacin - 133099-04-4 ISO, SMS, USAC
Darifenacin Hydrobromide - 133099-07-7 Tech Pack
Dutasteride IP, USP 164656-23-9 -
F Fesoterodine - 250214-44-9 -
Finasteride EP, IP, USP 98319-26-7 -
Flavoxate Hydrochloride BP 3717-88-2 -
Flibanserin - 167933-07-5 -
Flibanserin Hydrochloride - 147359-76-0 -
I Imidafenacin - 170105-16-5 -
M Mirabegron - 223673-61-8 -
N Naftopidil - 57149-07-2 -
Nalidixic Acid - 389-08-2 CEP, EDMF
O Oxybutynin - 5633-20-5 ISO, SMS, USAC Oxybutynin Chloride/ - 1508-65-2 - Oxybutynin Hydrochloride Phenazopyridine - 136-40-3 - P Hydrochloride Phosphate - 14265-44-2 -
Propiverine Hydrochloride - 54556-98-8 -
Prulifloxacin - 123447-62-1 ODMF, Tech Pack
R Retosiban - 820957-38-8 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 131 API Urology
Product Pharmacopoeia CAS No. Technical Document
S Sevelamer Carbonate - 845273-93-0 -
Sevelamer Hydrochloride - 152751-57-0 -
Solifenacin Succinate - 242478-38-2 -
Sucroferric Oxyhydroxide - 12134-57-5 -
Sulfamethoxypyrazine - 152-47-6 EDMF
T Tamsulosin - 106133-20-4 - 106463-17-6, Tamsulosin Hydrochloride USP - 80223-99-0 Terazosin - 63590-64-7 - 1953-02-2, Tiopronin - DMF 29335-92-0 124936-74-9, Tolterodine - - 124937-51-5 Trospium Chloride BP, EP 10405-02-4 USDMF
U Ulipristal Acetate - 126784-99-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 132 API Vasodilators
Product Pharmacopoeia CAS No. Technical Document
N N1-Methylnicotinamide - 3106-60-3 -
Naftidrofuryl - 31329-57-4 -
P Propatyl Nitrate - 2921-92-8 DMF AHF-Halal, CNAS(ISO17025), HACCP, ISO14001, Visnadine - 477-32-7 V ISO22000, ISO9001, NSF- cGMP, OU-Kosher, QC, SFDA-GMP, USFDA X Xanthinol Nicotinate BP, IP, USP 437-74-1 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 133 API Vitamins
Product Pharmacopoeia CAS No. Technical Document
22457-89-7, Benfotiamine - DMF B 22457-89-2 112965-21-6, Calcipotriol - - C 112828-00-9 Cholecalciferol (Vitamin D3) EP, USP 67-97-0 DMF, CEP, WC
Calcipotriol Monohydrate BP, EP 14657-22-5
Calcitriol - 32222-06-3 -
M Maxacalcitol - 103909-75-7 - Nicotinamide / BP, EP, USP 98-92-0 WC N Niacinamide Nicotinic Acid / Niacin BP, EP, USP 59-67-6 DMF, WC
P Phytonadione - 16033-41-3 - Riboflavin Phosphate USP 130-40-5 DMF, WC R Sodium Salt Riboflavin Sodium - 6184-17-4 Phosphate Rutin - 153-18-4 -
Z Zinc Ascorbate - 151728-40-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 134 API Wound Management
Product Pharmacopoeia CAS No. Technical Document
C Cetrimide BP, EP 8044-71-1 WC
Chlorhexidine Gluconate BP, EP, USP 18472-51-0 WC
Cis-Tranexamic Acid - 1197-17-7 -
T Tribenoside - 10310-32-4 -
Patent Disclaimer: Products protected by valid patents are not offered for sale in countries, where the sale of such products constitutes a patent infringement. The buyers should make their independent evaluation of the patent scenario for their respective markets and will be responsible for all patent related liabilities.
2021-01-11 © ExSyn Corp | All rights reserved. | www.exsyncorp.com 135